FULL PROGRAMME - Event Campaign

ICNCAOCCN

2012BRISBANEAUSTRALIA

© Robyn Mackenzie | Dreamstime.com

© Pniesen | Dreamstime.com

Joint Congress of the 12th International Child Neurology Congress and the 11th Asian and Oceanian Congress of Child Neurology Brisbane, Australia 27 May - 1 June 2012

INTERNAT

ION

AL CH ILD NEUROLO

GY

AS

SO

CIA

TION

THE AUSTRALIA AND NEW ZEALAND CHILD NEUROLOGY SOCIETY

Hosted byin

Full Programme

www.icnc2012.com

Joint 12th ICNC and 11th AOCCN

The Committee would like to acknowledge Brisbane Marketing for the support that they have provided in many aspects of the planning of the ICNC/AOCCN 2012 congress and for specific financial support provided through the Brisbane City Conference and Accommodation Bid Fund that has supported a number of delegates attending from low income countries.

The Committee is very grateful for the support of grant funding provided by the Australian Government’s International Seminar Support Scheme.

We acknowledge the contribution of Freehills and the Queensland Public Interest Law Clearing House Incorporated (QPILCH) in providing pro bono legal assistance for the International Child Neurology Congress and Asian and Oceanian Congress of Child Neurology.

we’ve bean reativebeancreative.com.au

www.icnc2012.com

27th May - 1st June 2012

Contents

Welcome Messages 2

Acknowledgements 4

General Congress Information 6

transport 10

Brisbane Practical Information 11

tours 12

sponsors 14

social events 15

Congress Centre Floor Plan 16

Awards 17

scientific Programme 18Full Programme Timetable 18

Sunday 27th May 24

Monday 28th May 28

Tuesday 29th May 36

Wednesday 30th May 46

Thursday 31st May 56

Friday 1st June 66

scientific Programme Information 72

Poster sessions 74Monday 28th May 74

Tuesday 29th May 79

Wednesday 30th May 86

Thursday 31st May 92

exhibitors List 97

Authors Index 99

2 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNW

eLCo

Me

Mes

sAG

es

WeLCoMe MessAGesWelcome Message From Chairs of the organising Committee

G’day and welcome to Brisbane!On behalf of the Local Organizing Committee, it is with great delight that we welcome you to the conjoined congresses of the 12th International Child Neurology Congress and the 11th Asian and Oceanian Congress of Child Neurology (ICNC/AOCCN 2012), in the wonderful location that is Brisbane, Queensland. The scientific content of this congress is of the highest quality and we thank the Scientific Committee for their excellent work in producing this. We are grateful to Developmental Medicine and Child Neurology for publishing the congress proceedings, and to all those researchers (both laboratory-based and clinical, and from all parts of the globe) who have submitted their work for presentation at ICNC/AOCCN 2012. We hope you enjoy the congress and wish you a wonderful stay in Brisbane.

Kate Riney Geoff Wallace Co-Chair Co-Chair Local Organising Committee Local Organising Committee ANZCNS ANZCNS

3www.icnc2012.com


WeL

CoM

e M

essA

Ges

Welcome Message From the President of the International Child neurology Association

It is my distinct honour, on behalf of the International Child Neurology Association, to welcome you to the 12th International Child Neurology Congress. As in past congresses, the scientific programme is of the highest calibre, emphasising not only the latest developments and advances in child neurology, but also reviewing current standards of care. We welcome participants from all over the world to engage in a collegial exchange of ideas and to enjoy the attractive socio-cultural program.

Harry Chugani President The International Child Neurology Association (ICNA)

Welcome Message From the President of Asian And oceanian Child neurology Association

On behalf of the Asian and Oceanian Child Neurology Association, I would like to welcome you to the conjoint meetings of the 12th ICNC and 11th AOCCN. Since its foundation in 1983, AOCNA has been fostering the study and dissemination of knowledge in all aspects of child neurology, particularly in the Asian and Oceanian regions. We welcome our AOCNA members from 25 Asian and Oceanian countries, to join with ICNA members in Brisbane to deepen not only our understanding of child neurology, but also our friendships.

Yoichi sakakihara President The Asian and Oceanian Child Neurology Association (AOCNA)

Welcome Message from the scientific Committee

We are delighted to present a world-class program representing the best of clinical and scientific child neurology from around the world. The scientific committee has worked equitably and efficiently to create a program of over 200 speakers with help from over 50 sub-speciality experts in child neurology. We hope you enjoy the program and catch up with old friends and colleagues.

Russell Dale Chair Scientific Committee

4 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNA

CKn

oW

LeD

GeM

ents ACKnoWLeDGeMents

overall organizing Committee

K Riney (Co-Chair) (ANZCNS)G Wallace (Co-Chair) (ANZCNS)H Chugani (ICNA)Y Sakakihara (AOCNA)R Webster (ANZCNS)J Wilmshurst (ICNA)H Yamamoto (AOCNA)

scientific Committee

R Dale (Chair)H ChuganiS HiroseY SakakiharaI TeinG Wallace

Local organizing Committee

K Riney (Co-Chair)G Wallace (Co-Chair)A CairnsS CalvertS MaloneM RyanC SharpeK SinclairR Webster

scientific Advisory Group

We would like to thank the following members of the scientific advisory group who have provided valuable input into the scientific content of the program including voting for plenary speakers:

K Abbott AustraliaG Agosta ArgentinaS Al-Yamani Saudi ArabiaB Anlar TurkeyH Arroyo ArgentinaS Ashwal USAA Bye AustraliaCS Chi TaiwanS Chiemchanya ThailandH Chugani USAP Colditz AustraliaH Cross UKP Curatolo ItalyR Dale AustraliaL De Meirleir BelgiumO Eeg-Olofsson SwedenD Ferriero USAY Fukuyama JapanV Ganesan UKM Guerreiro BrazilS Hirose JapanYS Hwang KoreaY Jiang ChinaV Kalra IndiaN Khan BangladeshDW Kim KoreaHD Kim KoreaJ Kim Korea

F Kirkham UKM Kurian UKA Kornberg AustraliaL Lagae BelgiumE Lahat Israel J Lawson AustraliaWT Lee TaiwanR Leventer AustraliaK Mack USAM Mackay AustraliaJ Mai ChinaT Matsuishi JapanB McDermott AustraliaJ Mink USAM Moharir CanadaL Nagarajan AustraliaC Newton KenyaS Niijima JapanK North AustraliaHT Ong SingaporeM Ortiz PhilippinesM Osawa JapanR Ouvrier AustraliaH Pusponegoro IndonesiaJ Qin ChinaT Rabanal PhilippinesA Raouf EgyptR Riikonen Finland

R Rust USAM Ryan AustraliaY Sakakihara JapanA Salonga PhilippinesI Scheffer AustraliaM Segawa JapanM Shevell CanadaP Singhi IndiaS Singhi IndiaY Suzuki JapanT Takahashi JapanJ Takanashi JapanI Tein CanadaD Thorburn AustraliaH Topaloglu TurkeyM Topcu TurkeyS Vanhatalo FinlandO van Nieuwenhuizen NetherlandsA Visudtibhan ThailandG Wallace AustraliaR Webster AustraliaJ Wilmshurst South AfricaSW Wong MalaysiaV Wong ChinaA Venter South AfricaH Yamamoto JapanY Yamashita Japan

5www.icnc2012.com


ACK

no

WLe

DG

eMen

tsAbstract Review Committee

B Anlar TurkeyS Ashwal USAA Bye AustraliaH Chugani USAH Cross UKP Curatolo ItalyR Dale AustraliaL De Meirleir Belgium V Ganesan UKS Hirose JapanM Johnston USAF Kirkham UKM Kurian UK

K Mack USAM Mackay AustraliaJ Mink USA M Moharir CanadaL Nagarajan AustraliaS Naidu USAC Newton KenyaK North AustraliaR Ouvrier AustraliaK Riney AustraliaS Rosenberg BrazilM Ryan AustraliaI Scheffer Australia

A Scheinberg AustraliaM Shevell CanadaP Singhi IndiaJ Takanashi JapanM Tardieu FranceI Tein CanadaD Thorburn AustraliaJ Wilmshurst South AfricaS Vanhatalo FinlandS Varadkar UKR Webster Australia

Congress Proceedings editorial team

K Riney (Chair)A CairnsS CalvertR DaleS MaloneK SinclairG WallaceR Webster

Poster tour Guides

Coordinator: M Ryan

Poster and Platform Prize Judges

Coordinator: C Sharpe

speed Date a speaker

Coordinator: R Webster

Meet a Mentor

Coordinator: C Sharpe

6 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNCo

nG

Ress

In

FoRM

AtIo

n

GeneRAL ConGRess InFoRMAtIon

Congress Venue

The 12th International Child Neurology Congress and 11th Asian and Oceanian Congress of Child Neurology (ICNC/AOCCN 2012) will be held at the Brisbane Exhibition and Conference Centre (BCEC).Venue address:Cnr Merivale and Glenelg Streets South Bank, Brisbane Queensland AustraliaWebsite: www.bcec.com.au

Registration Desk

The registration desk is located in the Main Foyer of the BCEC. The contact phone number is: + 61 (0)7 3308 3540

Congress bags and name badges can be collected from this point. Delegates must provide government-issued photo identification (eg passport, driver’s licence) along with a printed copy of their registration confirmation to facilitate

registration. Please note that name badges must be clearly displayed at all times or entry to sessions may be refused. Congress bags or printed material cannot be guaranteed for delegates who have not registered in advance.

speakers’ Presentation Centre

The Speakers’ Presentation Centre is located in room M10 on the Mezzanine Level of the BCEC. Facilities to review and amend presentations will be available and technical support will be provided. Speakers must submit their final Powerpoint presentation to the main desk in the Speakers Presentation Centre At LeAst 4 hours prior to their session start time. If speaking in an early morning session, talks should be uploaded the day before (excepting talks for Sunday 27th May).

ICnC/AoCCn talk Repository

Each Speaker at ICNC/AOCCN 2012 has been asked to provide an uploaded PDF summary

CBD

10min walk

15min walk

H

GoMA

E D W A R D S T R E E T

G E O R G E S T R E E T

W I L L I A M S T R E E T

Q U E E N S W H A R F

N O R T H Q U AY

TU

RB

OT

ST

RE

ET

AD

EL

AID

E S

TR

EE

T

TAN

K STREET

HERSC

HEL STREET

MA

RG

AR

ET

ST

RE

ET

MA

RY

ST

RE

ET

EL

IZA

BE

TH

ST

RE

ET

CH

AR

LO

TT

E S

TR

EE

T

AL

ICE

ST

RE

ET

A L B E R T S T R E E T

R O M A S TPA R K L A N D

C I T YB O TA N I C G A R D E N S

KURILPA BRIDGE

GO BETWEEN BRIDGE

ParliamentHouse

QUTGardens Point

Campus

LITTLE STANLEY ST

Cinema

S O U T H BA N K PA R K L A N D S

VICTORIA

BRIDG

E

7www.icnc2012.com


Con

GRe

ss

InFo

RMAt

Ion

of the top 3 latest advances in their field and the top 3 best suggested references to read in relation to their talk. Speakers have also been given the option of uploading a PDF of their full talk (or a modified version). This material is available freely for ICNC/AOCCN 2012 delegates using the following link:http://icnc2012.conference.net.au/icnc_portal.phpLog on using the following details:Username: ICNC2012 Password: childneuro2012

We hope you enjoy this unique resource which

will allow you to relax and enjoy the congress without the need for taking notes or typing. Note that photography (including of speakers slides) is strictly forbidden.

Language

English is the official language of the ICNC/AOCCN 2012.

Lunches and breaks

Lunches and morning and afternoon teas are served in the Exhibition Hall on the Foyer Level of the BCEC.

Facilities timetable

Sun 27th Mon 28th Tue 29th Wed 30th Thu 31st Fri 1st

Registration 07.30-18.30 06.30-18.30 06.30-18.00 06.30-18.00 06.30-18.00 06.30-18.00

Speakers Centre 07.00-18.30 07.00-17.30 07.00-17.30 07.00-17.30 07.00-17.30 07.00-16.30

Exhibition 18.00-19.00 10.00-17.00 10.00-17.00 10.00-17.00 10.00-17.00 10.00-17.00

Morning tea 10.00-10.30 10.00-10.30 10.00-10.30 10.00-10.30 10.00-10.30 10.00-10.30

Lunch 12.00-13.00 12.30-13.30 12.30-13.30 12.30-13.30 12.30-13.30 12.30-13.00

Afternoon tea 14.30-15.00 16.00-16.30 16.00-16.30 16.00-16.30 16.00-16.30 14.00-14.15

Congress secretariat

For problems during the congress, direct enquiries to the registration desk in the Main Foyer.

For urgent issues please phone: Registration: +61 (0)417 078082 Program: +61 (0)406 614721

For queries arising after the congress, please contact:ICNC/AOCCN 2012 Congress Secretariat 84 Queensbridge Street Southbank VIC 3006 AUSTRALIAt: +61 7 3308 3540 e: [email protected] f: +61 3 9682 0288 w: www.icnc2012.com

exhibition

A trade exhibition is held in conjunction with ICNC/AOCCN 2012. This is an integral part of the event and allows delegates the opportunity to be updated on the latest developments in products and services in the field of child neurology. The trade exhibition is located in the Exhibition Hall on the Foyer Level of the BCEC.

Certificate of Attendance

A certificate of attendance (including CME details) is available for all delegates for collection from the registration desk from Wednesday afternoon onwards.

Continuing Medical education

eACCMe (europe)The Joint 12th International Child Neurology Congress and 11th Asian and Oceanian Congress of Child Neurology (ICNC/AOCCN 2012) is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS)(www.uems.net). The ICNC/AOCCN is designated for a maximum of 30 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

8 www.icnc2012.com


nG

Ress

In

FoRM

AtIo

n

AMA PRA Category 1 Credits™ (UsA)Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at: www.ama-assn.org/go/internationalcme

MoC Program (Canada)Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

Fellows and trainees of the Royal Australasian College of Physicians Live educational activities recognized by the UEMS-EACCME for credits are deemed to be Group Learning Activities (Category 2) as defined by the MyCPD continuing professional development program of the Royal Australasian College of Physicians. Fellows and trainees of the RACP can apply for one credit for each hour attended of the academic program of the conference.

Community and Consumer Delegates

ICNC/AOCCN 2012 is primarily for health professionals. Community and consumer support groups have been welcomed to ICNC/AOCCN 2012 to allow partnerships with health professionals towards a common goal. Such delegates should understand that the presentations will contain medical jargon and may contain information and images that some will find distressing.

Questions from the open floor during sessions are invited from health professionals only. Non-health professional delegates will have the opportunity to approach speakers at the end of a session or informally during breaks to ask more personal questions or questions of a lay perspective.

Dress Code

ICNC/AOCCN 2012 promotes casual business attire for the duration of the congress week. At this time of year, Brisbane’s temperature ranges from 13 - 23°C (55 - 73°F), so a light jacket or sweater is recommended.

Mobile/cell phones

Mobile/cell phones and pagers/beepers must be turned off or to vibrate mode during all sessions so as not to disturb speakers or other delegates.

© B

risba

ne M

arke

ting

9www.icnc2012.com


Con

GRe

ss

InFo

RMAt

Ion

Photography

ICNC/AOCCN 2012 strictly prohibits all photography (flash, digital, or otherwise), audio and/or videotaping during the congress except by authorised photographers. Equipment could be confiscated for unauthorised recording. There will official photographers who will be capturing candid photos of the congress week. These photographs will be used in congress communications. Delegates should inform the Congress Office (by email or in writing) in advance of the congress week if they do not provide permission for this.

Replacement Badges

Please note that a fee of AUD$10 will be charged for a replacement badge.

Liability and Insurance

Australia and New Zealand Child Neurology Society Limited will not accept any liability for personal injury or loss/damage to property/belongings of participants or accompanying persons, either during or following the congress, tours or their stay in Brisbane. It is recommended that delegates arrange their own personal health, accident and travel insurance for themselves and accompanying persons.

on site information

Smoking policy The Congress has a strict no smoking policy.

Cloakroom The cloakroom is located at the Information Desk in the Main Foyer.

Disabled access All public areas of the BCEC can be accessed by wheelchair. Disabled car parking is also available.

Message board The message board is located near the Registration Desk in the Main Foyer.

Speakers room The Speakers’ Presentation Centre is located in room M10 on the mezzanine level.

Internet centre An internet station is located in the Exhibition Hall on the foyer level.

10 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNtR

An

sPo

Rt

tRAnsPoRt Getting to and from the VenueThe BCEC is 20 minutes by foot (1.5km) from the city via Victoria Bridge or the Goodwill Bridge. It can easily be reached by public transport.BusThe BCEC is a 10 minute walk from the Cultural Centre bus station (South East busway). Buses (including 66, 111, 222 & 330) leave from the Roma Street or the King George Square bus stations regularly.trainThe South Brisbane train station is a 10 minute walk to the BCEC.

Airport transfersBrisbane airport is approximately 20km north east of the BCEC (about 30 minutes in off peak traffic). Visitors can reach the city centre by taxi, shuttle bus or train.taxiFares from the airport to the city centre are around $40 or $45 to South Brisbane. Official taxi companies are: Black and White taxis ph: 131 008 www.blackandwhitecabs.com.au Yellow Cabs ph: 131 924 www.yellowcab.com.au Airport shuttle BusBuses connect the Roma Street Transit Centre (city centre), South Brisbane and the airport and depart every 30 minutes. Major city hotels are serviced on request. Fares are approximately $20 one way or A$38 return. Conxion website: www.coachtrans.com.autrainThe Airtrain leaves Brisbane airport regularly from 6.00am until 10.00 pm and takes about 30 minutes to get to South Bank station. The fare

is approximately $20 one way or $30 return. A special discounted fare of $20 return is available to Congress delegates on presentation of the authorising letter (available from the Secretariat). Airtrain website: www.airtrain.com.au

Public transportBrisbane has an integrated public transport system allowing travel on all modes of transport with the same ticket. Paper tickets can be bought from fare machines or drivers, however the GO CARD (electronic ticket) is recommended (from newsagents and convenience stores). Translink website: www.translink.com.au

Free City BusThe Loop is a free bus service around the centre of Brisbane, stopping at red CBD bus stops (see the Translink website).

BicyclesCityCycles allow bicycle hire from one of the 150 bike parking stations located across inner city Brisbane. Visitors to Brisbane can cycle for as little as $2 per day or $11 per week. Helmets are compulsory and come with some bikes or can be hired from a number of helmet vendors around the city. Citycycles website: www.citycycle.com.au

Car HireThe ICNC/AOCCN 2012 Committee recommends Alpha Car Hire for your car rental requirements. http://www.alphacarhire.com.au/#refid=CORPICMS01

Australians drive on the left hand side of the road. The speed limit is 50km/hr in built-up areas and 100km/hr on the open road. Drink driving is a serious offence with the legal limit at 0.05%. You must be over 21 years of age and hold a current driver’s licence to hire a car.

© B

risba

ne M

arke

ting

11www.icnc2012.com


BRI

sBA

ne

InFo

RMAt

Ion

BRIsBAne PRACtICAL InFoRMAtIon About Brisbane

Brisbane is the capital city of Queensland, Australia’s second largest state. With a population of only 1.8 million, it is the fastest growing capital city in Australia – probably due to the perfect weather! With a subtropical climate and average day-time temperatures even in winter of 20°C (68°F), you’ll need a hat and sunscreen all year.

Brisbane is positioned on both sides of the meandering Brisbane River – this means twice as many riverside cafés and restaurants, twice as many riverside walkways and plenty of activities related to sun, sand and water.

Located within 1½ hours of beautiful beaches, subtropical rainforests and the world’s largest sand islands, Brisbane is the perfect place to visit and plan your Queensland get-away.

Business Hours

Private and government offices are open from 09.00 – 17.00 with banks open from 09.30 – 16.00 Monday to Friday. Most shopping malls, department stores and supermarkets are open from 09.00 – 17.30 Monday to Thursday with late night shopping on Friday nights until 21.00. Weekend trading hours are 09.00 – 17.00 on Saturdays and 10.00 – 17.00 on Sundays. Convenience stores, tourist stores, pharamcies and supermarkets may have extended opening hours.

Credit Cards and Automatic teller Machines (AtMs)

Credit cards are accepted at most restaurants and shops, with Mastercard and Visa widely used.

Some retailers may not accept American Express or Diners Club or charge a fee for use.

Currency

The currency is Australian dollars ($AUD).

electricity

The electrical supply is 240 volts, 50 Hz. The connection for appliances is a flat 3-pin plug. Most city hotels provide 110 volts for shavers.

tax

Australia applies a tax to the purchase of both goods and services called the Goods and Services Tax (GST). The rate of tax that applies to taxable products and services is 10%. Tax is already included in the advertised prices. Non-Australian delegates may be eligible for a refund of GST via the Tourist Refund Scheme (www.customs.gov.au/site/page4646)

telephone

International dialling code: +61 Area code for Brisbane: 07

time Zone

Brisbane is 10 hours ahead of Greenwich Mean Time (GMT).

tipping

Tipping is not as widespread or regulated in Australia as it is in other parts of the world. Tipping is your prerogative, a reward for service. It is customary to tip hotel porters, and a gratuity of about 10% is usual in restaurants if good service is received. No service charge is added to hotel or restaurant bills.

© B

risba

ne M

arke

ting

12 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNto

URs

toURsA range of full and half day excursions are available throughout the congress week. These can be viewed and bookings made through the following link: http://static.icms.com.au/icnc2012/tours.pdf

Information regarding sights to see in and around Brisbane can be found at:

Visit Brisbane www.visitbrisbane.com.au

Insider Guide www.visitbrisbane.com.au/Travel/VisitorGuide/

Visit Queensland www.visit-queensland.com

suggestions close to BCeC

Free guided walks Explore Brisbane on a free guided walk to the outstanding city sights. Tours start from the Brisbane Visitor Information Booking Centre (Queen St Mall) Monday to Friday at 12.00.

southbank ParklandsWithin this urban oasis, you can walk along the Brisbane River, visit the Streets beach, ride the Wheel of Brisbane and finish with a BBQ lunch.

River City Cruises This 1½ hour sightseeing cruise, with an informative commentary, showcases the sights of Brisbane. Cruises depart daily at 10.30 and 12.30 from Southbank Parklands Jetty A.

Queensland MuseumLearn about dinosaurs, history, geography and natural disasters – all with a Queensland flavour.

sciencentreThe Sciencentre offers hours of interactive, science-based fun for kids of all ages.

Queensland Art Gallery/Gallery of Modern Art (QAGoMA)The Gallery of Modern Art (GoMA), which includes the Australian Cinematheque, has numerous interactive displays for both adults and children. Together with the Art Gallery, which displays Queensland’s premier art collection, QAGOMA is unrivalled nationally.

Queensland Performing Arts CentreFeaturing world class performances from ballet to opera to theatre, QPAC is the cultural centre of Brisbane.

suggestions within Brisbane

Mt Coot-tha Botanic Gardens and LookoutVisit the gardens and enjoy free volunteer guided walks (bus route 471 from the city) departing the Information Centre at 11.00 or 13.00, Monday to Saturday. Travel further and visit the lookout with views over Brisbane and enjoy lunch or dinner at the Summit Restaurant.

Walkabout Creek Visitor CentreOnly a short bus trip from the city (route 385), see kangaroos, spotted quolls and other native wildlife in their natural habitat. Have a break with lunch in the Green Tree Frog cafe.

Lone Pine Koala sanctuarySet in riverside bushland, visit over 130 koalas, kangaroos, wombats and other native animals. Get there via bus (route 430 from the Cultural Centre bus station) or the Mirimar Boat Cruise.

© B

risba

ne M

arke

ting

© B

risba

ne M

arke

ting

13www.icnc2012.com


toU

Rs

Brisbane AdventuresAbseil down Kangaroo Point cliffs, climb the Story Bridge or kayak down the Brisbane River. If you are looking for excitement, choose your own adventure.

Day trips from Brisbane

Day cruises to Moreton Bay IslandsChoose from a variety of day cruises to Moreton and Stradbroke Islands and enjoy adventures such as sand-boarding, feeding wild dolphins, snorkelling with dugongs & wobbegongs and whale watching

Gold Coast beaches & hinterlandVisit the world famous beaches of the Gold Coast or bushwalk in the tropical rainforests of Tambourine or Springbrook National Parks. Walk among the trees with the tree-top walk at Binna Burra.

sunshine Coast & hinterlandSurf, shop or lie on the beach at Noosa or visit

the scenic villages of Maleny and Montville overlooking the spectacular Glasshouse Mountains.

Fraser IslandVisit the World Heritage listed Fraser Island - the largest sand island in the world. With long white beaches and clear freshwater lakes, it is a place of exceptional beauty.

Gold Coast theme ParksDreamworld, Sea World, Wet ‘n’ Wild, Movie World, Currumbin Wildlife Sanctuary are all within an easy day trip from Brisbane. Passes are available for multiple visits.

sunshine Coast theme ParksCrikey, you can visit Australia Zoo, the Ettamogah Pub and Aussie World, Underwater World or the Big Kart Track. Passes are available for multiple visits.

© B

risba

ne M

arke

ting

14 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNsP

on

soRs

sPonsoRs

MAJoR sPonsoRs

GALA DInneR sPonsoR

A U S T R A L I A N & N E W Z E A L A N D

Association of Neurologists

sPonsoRs

15www.icnc2012.com


soCI

AL

eVen

ts

soCIAL eVentsWelcome Reception

The Welcome Reception is in Exhibition Hall on the Foyer Level from 18.00 – 19.00 on Sunday 27th May. Experience a taste of Australian culture along with some of our furry and not-so furry native animals accompanied by a gourmet barbecue.

Tickets are included for full registration delegates. Additional tickets can be purchased at a cost of AUD$80.

Gala Dinner

The Gala Dinner will be held in the Plaza Ballroom on Thursday 31st May. It will showcase Australian cuisine and wine with a culinary selection of local ingredients. Predinner drinks with an Indigenous performer will be followed by a cultural performance with a paediatric theme. Enjoy the opportunity to meet with colleagues and friends from Australia and internationally.

Tickets are AUD$130 each and include drinks with canapes and a three course meal. Purchase tickets on site from the Registration Desk - these will only be available on Monday 28th May.

© B

risba

ne M

arke

ting

16 www.icnc2012.com


nG

Ress

Cen

tRe

FLo

oR

PLA

n

ConGRess CentRe FLooR PLAn

Foyer

Plaza Ballroom FoyerTo BCEC onMerivale St

Plaza Ballroom

Plaza North Terrace

Green Room

P11 P10 P9 P8 P7 P6Plaza Auditorium Foyer

Plaza Ballroom Foyer

Plaza Central Terrace

Stairs to Sky Level

Lobby

Lift

Lift

Plaza Ballroom

Plaza Auditorium

Lift

Plaza Terrace Room

Plaza Ballroom

Foyer

Plaza Terrace (outdoors)

Plaza Foyer

PTR Concourse

Car LiftPlaza Gallery Escalators

Lifts

P5

P4

P3

P2

P1

Stairs

Ballroom Dressing

Room

Bar Bar

Great Hall Concourse

Great Hall Dock

Exhibition Hall

Q2

Q1

Door 2

Door 3

F1

Merivales Restaurant, Cafe, Bar

MainFoyer

Main Entrance

Terr

ace

BR1

BR2

Conv 1

Lifts

Tasting Room

Escalators

M10

M9 M8 M7 M6 M5

Speakers Presentation

Centre

Door 9

Q1

Q2

Great Hall Mezzanine ConcourseDoor 5

Door 7

Door 8

Door 6

Mezzanine Foyer

Escalators

Escalators

M4 M3

M2

M1Mezz Cafe

1

Mezz Cafe

2

Ramp

StairsLifts

Bar

Lifts

VIPSuite

Exhibition Hall

FoYeR LeVeLMeZZAnIne LeVeL

PLAZA LeVeL

17www.icnc2012.com


AWA

RDs

AWARDsAwards

The following are recipients of ICNA awards:

John stobo Prichard AwardBernard Dan Belgium

sheila Wallace Award Samson Gwer Kenya

Frank Ford Memorial AwardRobert Ouvrier Australia

ICnA travel BursaryKonstantin Pushkarev Kazakhstan Fereshteh Saeed Tehrani Iran

Bursaries

We are particularly grateful for the support of the Australian Government’s AusAID International Seminar Support Scheme and to the Brisbane City Conference and Accommodation Bid Fund for support for delegates attending ICNC/AOCCN 2012.

AnZCns travel Bursary AwardsAngeline Frank-Briggs Nigeria Arushi Saini India Parayil Bindu India Eppie Yiu Australia Janet Adajar Philippines Mahesh Kamate India Maina Kava Canada Prashant Jauhari India Sanjaya Mandadige Fernando Sri Lanka Sekhar Pillai Australia Suvasini Sharma India Tajul Arafin Tajudin Malaysia Mac Mallewa Malawi

AusAID/Isss FundingAngelina Kakooza-Mwesige Uganda Richard Idro Uganda Michael Kihara Kenya Kyaw Linn Myanmar Sunil Sherchan Nepal Naila Khan Bangladesh Narayan Chandra Saha Bangladesh Loudella Calotes-Castillo Philippines Rosario Marissa Lukban Philippines

18 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNFU

LLtI

Met

AB

LesC

Ien

tIFI

CPR

oG

RA

MM

e

Sund

ay 27

th M

ayM

onda

y 28t

h M

ayTu

esda

y 29t

h M

ay

Brea

kfas

t Te

achi

ng 1

Eye

mov

emen

t dis

orde

rs07

.20-0

8.20

Brea

kfas

t Sy

mpo

sium

1

Epile

psy

07.20

-08.2

0Op

enin

g Ce

rem

ony

08.00

-08.2

5

The M

etab

olic

Dete

rmina

nts

of N

euro

logica

l Di

seas

es08

.15 - 1

6.30

Tour

ette

Sy

ndro

me a

nd

Gene

tic M

ovem

ent

Diso

rder

s 08

.30 - 1

7.15

Adva

nces

in

Rese

arch

and

Ther

apy i

n Au

tism

Spec

trum

Di

sord

ers

08.30

- 17.0

0

Malf

orm

ation

s of

Corti

cal

Deve

lopm

ent

08.30

- 17.1

5

John

Stob

o Pric

hard

Awar

d Le

ctur

eAn

gelm

an sy

ndro

me:

an in

spiri

ng m

olecu

lar,

phys

iolog

ical a

nd cl

inica

l sym

phon

y08

.30-0

9.10

Shei

la W

alla

ce Aw

ard

Lect

ure

Chall

enge

s and

Rese

arch

Prior

ities

in M

anag

emen

t of

Child

hood

Acut

e Com

a in s

ub-S

ahar

an Af

rica

08.30

-09.1

0

Plen

ary

Adva

nces

in th

e gen

etics

of ep

ileps

y09

.15-1

0.00

Plen

ary

Auto

imm

une e

ncep

halit

is09

.15-1

0.00

Mor

ning

Tea 1

0.00-

10.30

Mor

ning

Tea &

Post

ers 1

0.00-

10.30

Mor

ning

Tea &

Post

ers 1

0.00-

10.30

Para

llel S

essio

ns 10

.30-1

2.30

Para

llel S

essio

ns 10

.30-1

2.30

Epilepsy

CNS Infection

Metabolic

Movement Disorders

Epilepsy

CNS Infection

Metabolic

Neurocritical Care

Lunc

h12

.00-1

3.00

Lunc

h &

Post

ers

12.30

-13.3

0Lu

nch

& Po

ster

s12

.30-1

3.30

Spee

d Da

ting

12.45

-13.1

5

SIG

Dista

nce

Lear

ning

12.45

-13.3

0

Spee

d Da

ting

12.45

-13.1

5

SIG

EpiN

et12

.45-

13.30

SIG

Healt

h Ou

tcom

es12

.45-

13.45

Para

llel S

essio

ns 13

.30-1

4.30

Para

llel S

essio

ns 13

.30-1

4.30

Epilepsy

CNS Infection

Metabolic

Movement Disorders

Clinical Research Methodology

Neuroimaging

Metabolic

Challenges in Child

Neurology 1

19www.icnc2012.com


FULL

tIM

etA

BLe

sCIe

ntI

FIC

PRo

GR

AM

Me

Afte

rnoo

n Te

a 14.3

0-15

.00

Plat

form

Pre

sent

atio

ns14

.30-1

6.00

Plat

form

Pre

sent

atio

ns14

.30-1

6.00

Workshop Neurology of reflex syncope 14.30-18.00

Afte

rnoo

n Te

a & Po

ster

s16

.00-1

6.30

Afte

rnoo

n Te

a & Po

ster

s16

.00-1

6.30

Mee

t a M

ento

r16

.10-1

6.30

Mee

t a M

ento

r16

.10-1

6.30

Para

llel S

essio

ns 16

.30-1

8.00/

18.30

Para

llel S

essio

ns 16

.30-1

8.00/

18.30

Neurocutaneous & Neurogenetic Disorders

Neurogenetics

Metabolic

Movement Disorder

Epilepsy

CNS Infection

Metabolic

Neurocritical Care

Clos

e 16.3

0/17

.15

Wel

com

e Rec

eptio

n18

.00-1

9.00

Novartis Symposium18.30-19.30

Clos

e 18.0

0/18

.30

AOCNA National Delegate Meeting18.30-21.30

Clos

e 18.0

0/18

.30

ICNA Annual General Meeting

18.30-19.30

20 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNFU

LLtI

Met

AB

LesC

Ien

tIFI

CPR

oG

RA

MM

e

Wed

nesd

ay 30

th M

ayTh

ursd

ay 31

st M

ayFr

iday

1st J

une

Brea

kfas

t Te

achi

ng 2

EEG

07.20

-08.2

0

Brea

kfas

t Sy

mpo

sium

2

Cere

bral

palsy

07.20

-08.2

0

Brea

kfas

t Sy

mpo

sium

3

Cere

bral

palsy

07.20

-08.2

0

Brea

kfas

t Sy

mpo

sium

4

Cere

bella

r dis

orde

rs07

.20-0

8.20

Brea

kfas

t Te

achi

ng 3

Epile

psy

07.20

-08.2

0

Brea

kfas

t Te

achi

ng 4

Sleep

07.20

-08.2

0

Plen

ary

New

and e

xciti

ng im

aging

tech

nique

s tha

t help

to

diagn

ose a

nd in

creas

e the

unde

rstan

ding o

f con

genit

al an

d acq

uired

brain

diso

rder

s 08

.30-0

9.10

Plen

ary

The p

oten

tial o

f ste

m ce

ll the

rapy

in 21

st ce

ntur

y pae

diatri

c neu

rolog

y 08

.30-0

9.10

Fran

k For

d M

emor

ial A

war

d Le

ctur

eAu

strala

sian c

ontri

butio

ns to

child

neur

ology

08.30

-09.1

0

Plen

ary

Timing

issu

es in

perin

atal

brain

injur

y: im

pact

on th

erap

y 09

.15-1

0.00

Plen

ary

Pedia

tric s

troke

trea

tmen

t - ba

lancin

g risk

s an

d ben

efits

09.15

-10.0

0

Plen

ary

Upda

te on

cong

entia

l myo

path

ies09

.15-1

0.00

Mor

ning

Tea &

Post

ers 1

0.00-

10.30

Mor

ning

Tea &

Post

ers 1

0.00-

10.30

M

orni

ng Te

a 10.0

0-10

.30

Post

er &

Pla

tform

Awar

ds 10

.15-1

0.30

Para

llel S

essio

ns 10

.30-1

2.30

Para

llel S

essio

ns 10

.30-1

2.30

Para

llel S

essio

ns 10

.30-1

2.30

Cerebral Palsy

Challenges in Child Neurology 2

Neuroimmunology

Neurocritical Care

Muscle & Nerve

Stroke

Development & Cognition

Neonatal Neurology


Stroke

Muscle & Nerve

Neonatal Neurology

Lunc

h &

Post

ers

12.30

-13.3

0Lu

nch

& Po

ster

s12

.30-1

3.30

Lunc

h12

.30-1

3.00

Spee

d Da

ting

12.30

-13.0

0Sp

eed

Datin

g12

.45-1

3.15

SIG

Head

ache

12.45

-13

.45

ICNA

CO

D12

.45-

13.45

Spee

d Da

ting

12.45

-13.1

5

SIG

Vigab

atrin

12.45

-13.1

5SI

G St

roke

12.45

-13

.45

Para

llel S

essio

ns 13

.00-1

4.00

New Gene Discoveries in Neurogenetics

Stroke

Muscle & Nerve

Challenges in Child

Neurology 4

Para

llel S

essio

ns 13

.30-1

4.30

Para

llel S

essio

ns 13

.30-1

4.30

Cerebral Palsy

Neuroimaging

Neuro-immunology

Neurogenetics

Neurogenetics

Neuroimaging


Challenges in Child

Neurology 3

Afte

rnoo

n Te

a 14.0

0-14

.15

21www.icnc2012.com


FULL

tIM

etA

BLe

sCIe

ntI

FIC

PRo

GR

AM

Me

Plat

form

Pre

sent

atio

ns14

.30-1

6.00

Workshop Peripheral Neuropathy and Neuronopathy 14.30-17.00

Plat

form

Pre

sent

atio

ns14

.30-1

6.00

SIG

Cere

bella

r14

.30-

15.30

Workshop Autoantibody mediated CNS disorders 14.30-17.00

Para

llel S

essio

ns 14

.15-1

6.15

Stroke


Muscle & Nerve

Neonatal Neurology

Afte

rnoo

n Te

a & Po

ster

s16

.00-1

6.30

Afte

rnoo

n Te

a & Po

ster

s16

.00-1

6.30

Mee

t a M

ento

r16

.10-1

6.30

Mee

t a M

ento

r16

.10-1

6.30

Clos

ing

Cere

mon

y16

.15-1

7.00

Para

llel S

essio

ns 16

.30-1

8.00/

18.30

Para

llel S

essio

ns 16

.30-1

8.00/

18.30

Cerebral palsy

Epilepsy

Neuroimmunology

Neurogenetics

Epilepsy

Stroke

Muscle & Nerve

Neonatal Neurology

Afric

an Ch

ild

Neur

olog

y As

socia

tion

Mee

ting

18.00

-19

.00

ANZC

NS

Mem

bers

M

eetin

g18

.00-

19.00

Clos

e 18.0

0/18

.30AO

CNA

Gene

ral

Asse

mbl

y18

.30-

19.30

Clos

e 18.0

0/18

.30

Gala

Din

ner

19.00

-23.0

0

A multidisciplinary approach is required for TSC

ChildNeurologists

Connecting patients with optimal care3-5

Tuberous sclerosis complex (TSC) is an inherited autosomal dominant disorder characterised by the development of unusual tumour-like growths, in a variety of tissues and organs.2

The paediatric neurologist plays a key role • central to TSC management due to high prevalence of neurological

symptoms in children1,2

• best prepared to coordinate patient care (with a focus on dermatologists, nephrologists, and urologists)1

A multidisciplinary approach is required for TSC1-5

Novartis Pharmaceuticals Australia Pty Ltd, ABN 18 004 244 160, 54 Waterloo Road, North Ryde, NSW 2113. Item No: AFI0073. AFIN5466 BBK05/12

References: 1. Yates JRW. Eur J Hum Genet. 2006;14(10):1065-1073. 2. Leung AKC. J Ped Health Care. 2007;21(2):108-114. 3. Napolioni V, Curatolo P. Curr Genom. 2008;9(7):475-487. 4. Massachusetts General Hospital. How TSC Affects the Body: Mental Health. Brain: mental health and behavior. http://www2.massgeneral.org/livingwithtsc/affects/mental_health2.htm. Accessed April 26, 2012. 5. Massachusetts General Hospital. Tuberous Sclerosis Complex: Treatment. http://www2.massgeneral.org/livingwithtsc/about/treatment.htm Accessed April 26, 2012.

23www.icnc2012.com


sCIe

ntI

FIC

PRo

GR

AM

Me

Expert Exchange on Selecting Appropriate Intervention for Treatment of SEGA

DINNER SYMPOSIUM Monday, May 28th 18:30 – 19:30

Brisbane Convention and Exhibition Centre, Meeting Room M3 Brisbane, Australia

18:30 – 18:45 ThERAPEUTIC ChAllENGES IN ThE MANAGEMENT Of TSC Dr. John Lawson

18:45 – 19:00 ClINICAl DATA ON mTOR INhIBITION fOR SEGA IN PATIENTS WITh TSC Dr. Sergiusz Jóźwiak

19:00 – 19:30 INDIvIDUAlIzING PATIENT CARE – PANEl DEBATE Drs. John Lawson, Sergiusz Jóźwiak, Finbar O’Callaghan

fACUlTY

John lawson, B.Med, fRACP, PhD Medical Advisor Australasian TS Society

Staff Specialist in Child Neurology Sydney Children’s Hospital

University of New South Wales Randwick, Australia

Sergiusz Jóźwiak, MD, PhD Member of the TSC Alliance International

Scientific Advisory Board Head of the Department of Child Neurology

The Children’s Memorial Health Institute Warsaw, Poland

finbar O’Callaghan, MA, MB ChB, MSc, PhD, fRCP, fRCPCh Reader and Hon. Consultant in Pediatric Neurology

University of Bristol and Bristol Royal Hospital for Sick Children Director of Bath Tuberous Sclerosis Clinic and

Medical Advisor to Tuberous Sclerosis Association Bristol, UK

Novartis Pharmaceuticals Australia Pty Ltd, ABN 18004244160,

54 Waterloo Road, North Ryde, NSW 2113 G-AFI-1039618

24 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNsU

nD

AY27

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

Sunday 27th MayGREAT HALL Q1 GREAT HALL Q2 MEETING RM 3 MEETING RM 4

Precongress SymposiumThe Metabolic Determinants of

Neurological Diseases08.15 - 16.30

Precongress SymposiumTourette Syndrome and Genetic

Movement Disorders 08.30 - 17.15

Precongress SymposiumAdvances in Research and Therapy in

Autism Spectrum Disorders 08.30 - 17.00

Precongress SymposiumMalformations of Cortical Development

08.30 - 17.15

Morning Tea 10.00-10.30

Lunch12.00-13.00

Afternoon Tea 14.30-15.00

Close 16.30/17.15

Welcome ReceptionExhibition Hall

18.00-19.00

25www.icnc2012.com


sUn

DAY

27tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

sUnDAY 27tH MAY08:30 toURette sYnDRoMe AnD GenetIC MoVeMent

DIsoRDeRs Q1Chairs: Huei-Shyong Wang (Taiwan) & Russell Dale (Australia)

Tourette syndrome: clinical aspects and updatesJonathan Mink, USA

Tourette syndrome: update in neurobiologyHarvey Singer, USA

10:00-10.30 MoRnInG teA

Tourette syndrome: insight into pathophysiology using electrophysiology and saccade examinationYoshiko Nomura, Japan

Tourette syndrome: update in therapeutics Harvey Singer, USA

12:00-13.00 LUnCH

The emergence of movement disorders in children: defining the developmental contextMasaya Segawa, Japan

Use of copy number variant analysis in suspected genetic movement disordersRussell Dale, Australia

14:30-15.00 AFteRnoon teA

Update in genetic dystoniasJonathan Mink, USA

Myoclonus dystonia or benign hereditary chorea?Nardo Nardocci, Italy

Genetics of Juvenile ParkinsonismCarolyn Sue, Australia

17:15 CLose

08:15 tHe MetABoLIC DeteRMInAnts oF neURoLoGICAL DIseAses Q2Chairs: Cheuk-Wing Fung (Hong Kong) & Linda De Meirleir (Belgium)

Introduction

Prevalance and approach to mitochondrial disorders in Australia and South-East AsiaDavid Thorburn, Australia

The eye in metabolic diseases: clues to diagnosisBwee-Tien Poll-The, Netherlands

26 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNsU

nD

AY27

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e


Clinical evaluation and emergency management of inborn errors of metabolism presenting with neonatal encephalopathyJohn Christodoulou, Australia

The metabolic determinants of infantile epilepsyLinda De Meirleir, Belgium

12:00-13.00 LUnCH

Approach to the diagnosis of metabolic myopathies and recurrent myoglobulinuriaIngrid Tein, Canada

Approach to the diagnosis of metabolic neuropathiesRobert Ouvrier, Australia


Neurometabolic diseases detectable by newborn screening: advances in Electrospray Tandem MS-MSBridget Wilcken, Australia

Palliative care issues in the setting of a multidisciplinary neurometabolic clinicChitra Prasad, Canada; Narayan Prasad, Canada

16:30 CLose

08:30 ADVAnCes In ReseARCH AnD tHeRAPY In AUtIsM sPeCtRUM DIsoRDeRs AnD ReLAteD ConDItIons M3Chairs: Toyojiro Matsuishi (Japan) & Yushiro Yamashita (Japan)

Autism spectrum disorders: neurological perspectivePaddy Grattan-Smith, Australia

Cognitive function of ASDAtsuko Gunji, Japan

Clumsiness in ASD - how do we recognise, assess and intervene?Akio Nakai, Japan


Psychiatry and psychology of autistic spectrum disordersDavid Dossetor, Australia

Neuroimaging of ASDMasayuki Sasaki, Japan

12:00-13.00 LUnCH

Molecular systems and genomics: abstracting cognitive disorderCharles Claudianos, Australia

27www.icnc2012.com


sUn

DAY

27tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

Pathophysiology of ASDYoshiko Nomura, Japan


Evidence based management of ASDVirgina Wong, Hong Kong

Advances in Rett syndrome clinical researchHelen Leonard, Australia

The genetic aspect of Rett syndromeJohn Christodoulou, Australia

17:00 DIsCUssIon AnD CLose

08:30 MALFoRMAtIons oF CoRtICAL DeVeLoPMent M4Chairs: Mitsuhiro Kato (Japan) & Rick Leventer (Australia)

Covering the brain: normal cortical developmentSeong Seng Tan, Australia

Wiring the brain: normal axon guidance and pathfindingLinda Richards, Australia


Update on the classification of MCDJames Barkovich, USA

Lissencephaly and related disordersMitsuhiro Kato, Japan

12:00-13.00 LUnCH

Grey matter heterotopia and polymicrogyriaRick Leventer, Australia

Classification and management of focal cortical dysplasiaHelen Cross, UK


Fetal diagnosis of MCDTally Lerman-Sagie, Israel

New and emerging imaging techniques to detect subtle MCDGraeme Jackson, Australia

Case studies: approach to the diagnosis of MCDRick Leventer, Australia; Panel discussion

17:15 CLose

18:00-19:00 WeLCoMe ReCePtIon exHIBItIon HALL

28 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNM

on

DAY

28tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

Monday 28th MayGREAT HALL Q1 & Q2 MEETING RM 3 MEETING RM 4 MEETING RM 1 & 2 MEETING RM 5 & 6 MEETING RM 7 & 8 PLAZA RMS

Opening Ceremony08:00-08:25

John Stobo Prichard Award Lecture

Angelman syndrome: an inspiring molecular,

physiological and clinical symphony

08.30-09.10

PlenaryAdvances in the

genetics of epilepsy09.15-10.00

Morning Tea & Posters 10.00-10.30

Parallel Sessions 10.30-12.30

EpilepsyEpilepsy surgery in

children: are we doing it right?

CNS InfectionUpdate on endemic and epidemic CNS infection: an Asian

perspective

MetabolicUpdate on

Neurometabolic Therapies 1

Movement Disorders

Neurotransmitter disorders

Lunch & Posters12.30-13.30

Speed Dating12.45-13.15

SIG Distance Learning

12.45-13.30


EpilepsyThe new ILAE

classification of the epilepsies: the debate

CNS InfectionManagement and prevention of CNS infection: global

perspectives

MetabolicNewborn screening

Movement Disorders

Stereotypy in children: clinical features, associations and

evolution

Platform Presentations14.30-16.00

Afternoon Tea & Posters16.00-16.30 Meet a Mentor

16.10-16.30

Parallel Sessions 16.30-18.00/18.30

Neurocutaneous & Neurogenetic

DisordersNew therapies in neurogenetic CNS

disorders

NeurogeneticsNew molecular

technologies to discover

disease-related or susceptibility genes

MetabolicBasic biology of

organelles and their associated childhood

neurological disease 1

Movement DisorderDiagnostic challenges:

video sessions

Novartis Symposium

Expert Exchange on Selecting Appropriate

Intervention for Treatment of SEGA

Meeting Rm 318.30-19.30

Close 18.00/18.30 AOCNA National Delegate Meeting

18.30-21.30

29www.icnc2012.com


Mo

nD

AY28

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

MonDAY 28tH MAY08:00-08:25 oPenInG CeReMonY Q1+2

Address from the President of AOCNAYoichi Sakakihara, Japan

Address from the President of ICNAHarry Chugani, USA

Address from the Scientific CommitteeRussell Dale, Australia

Address from the Local Organizing CommitteeKate Riney, Australia; Geoff Wallace, Australia

08:30-09:10 JoHn stoBo PRICHARD AWARD LeCtURe Q1+2 IntroductionHarry Chugani, USA

Angelman syndrome: an inspiring molecular, physiological and clinical symphony Bernard Dan, Belgium

09:15-10.00 PLenARY LeCtURe Q1+2 IntroductionRussell Dale, Australia

Advances in the genetics of epilepsy Sam Berkovic, Australia

10:00-10:30 MoRnInG teA AnD PosteRs exHIBItIon HALL

10:30-12:30 ePILePsY Q1+2 epilepsy surgery in children: are we doing it right? Chairs: KP Chang (Taiwan) / Helen Cross (UK)

Pre-surgical evaluation: how little is enough? Simon Harvey, Australia

Non-lesional cases: when is enough enough? Helen Cross, UK

Epilepsy surgery outcome: seizures and neurodevelopment Heung Dong Kim, Korea

Medication withdrawal post surgery: should we withdraw and when? Kees Braun, Netherlands

10:30-12:30 Cns InFeCtIon M3Update on endemic and epidemic Cns infection: an Asian perspectiveChairs: Fei Yin (China) / Rei-Cheng Yang (Taiwan)

30 www.icnc2012.com


on

DAY

28tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

Enterovirus 71 rhombencephalitis Ching-Shiang Chi, Taiwan

Japanese B encephalitis Pratibha Singhi, India

Subacute sclerosing panencephalitis Marissa Lukban, Philipines

Acute encephalopathy; devastating complications of influenza and other viral infections Masashi Mizuguchi, Japan

10:30-12:30 MetABoLIC M4 Update on neurometabolic therapies 1 Chairs: Bwee-Tien Poll-The (Netherlands) / Sylvia Stöckler (Canada)

Latest advances in mitochondrial therapies John Christodoulou, Australia

Pathogenesis of MELAS and L-arginine therapy Yasu Koga, Japan

Efficacy of enzyme replacement therapy for mucopolysaccharidoses Linda De Meirleir, Belgium

Novel therapeutic strategies for fatty acid oxidation disorders Ingrid Tein, Canada

10:30-12:30 MoVeMent DIsoRDeRs M1+2 neurotransmitter disorders Chairs: Kenji Sugai (Japan) / Jonathan Mink (USA)

Dopa responsive dystonia (Segawa disease): from first patients to gene discovery. Implications to the pathophysiology of dystonia Masaya Segawa, Japan

Tyrosine hydroxylase deficiency Michèl Willemsen, The Netherlands

6 PTPS deficiency- diagnosis, management and outcomes Asuri Prasad, Canada

Monoamine biosynthesis disorders: from clinical findings to animal studies Wang-Tso Lee, Taiwan

12:30-13:30 LUnCH AnD PosteRs exHIBItIon HALL

12:45-13:30 sPeCIAL InteRest GRoUP M7+8 Distance learning in paediatric neurologyFinbar O’Callaghan, UK

31www.icnc2012.com


Mo

nD

AY28

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

13:30-14:30 ePILePsY Q1+2 the new ILAe classification of the epilepsies: the debate Chairs: Ingrid Scheffer (Australia) / Yong Seung Hwang (Korea)

The new organisation Mary Connolly, Canada

The good and the bad Yue-Hua Zhang, China

The way forward Christian Korff, Switzerland

13:30-14:30 Cns InFeCtIon M3 Management and prevention of Cns infection: global perspectives Chairs: Pongsakdi Visudhiphan (Thailand) / Richard Idro (Uganda)

Recent advances in the management of CNS infections Pratibha Singhi, India

H1N1 influenza and the brain: what have we learnt? Are we prepared? Robert Booy, Australia

13:30-14:30 MetABoLIC M4 newborn screening Chairs: Linda deMeirleir (Belgium) / Chitra Prasad (Canada)

Expanded newborn screening: reducing harm, assessing benefit Bridget Wilcken, Australia

Update on newborn screening in Pompe’s disease Yin-Hsiu Chien, Taiwan

13:30-14:30 MoVeMent DIsoRDeRs M1+2 stereotypy in children: clinical features, associations and evolution Chairs: Zhisheng Liu (China) / Rob Rust (USA)

Stereotypies in autism and Rett syndrome Teresa Temudo, Portugal

Stereotypies in the normally developed child: what happens at follow-up? Harvey Singer, USA

14:30-16:00 PLAtFoRM sessIon Q1+2 epilepsy Chairs: Kate Riney (Australia) / Melinda Nolan (New Zealand)

A1-P1 Characteristics and predictors of seizures in children with cerebral sino-venous thrombosis Chee-Ming Teh, Canada & Malaysia

32 www.icnc2012.com


on

DAY

28tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

A1-P2 Acute seizure aggravation due to intravenous phenytoin administration in children with Dravet syndrome Sharon Gilchrist, Australia

A1-P3 The British Paediatric Neurology Surveillance Unit study of migrating partial seizures in infancy: a national surveyAmy McTague, UK

A1-P4 NIPA2 located in 15q11.2 is mutated in patients with childhood absence epilepsyYuwu Jiang, China

A1-P5 Association of proportion of optimal birth weight with childhood onset epilepsy in a population based cohortMatthew Cooper, Australia

A1-P6 Do recessive mutations in SCN1B cause Dravet syndrome? Young Ok Kim, Australia

14:30-16:00 PLAtFoRM sessIon M3 Cns infection Chairs: Kuang-Lin Lin (Taiwan) / Hussain Ismail (Malaysia)

B1-P1 Glial markers in the cerebrospinal fluid in cases of acute encephalopathy with biphasic seizures and late reduced diffusion (AESD)Keisuke Nakajima, Japan

B1-P2 Changing trends in incidence and aetiology of acute non-traumatic coma in children in rural coastal KenyaSamson Gwer, The Netherlands & Kenya

B1-P3 Description of 52 cases of HIV encephalopathy in a paediatric population in Cape TownKirsty Donald, South Africa

B1-P4 Changes of cerebrospinal fluid markers in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS)Rie Miyata, Japan

B1-P5 Causes of fulminant encephalitis in children: virus or autoantibody?Jainn-Jim Lin, Taiwan

B1-P6 Oxidative stress in acute encephalopathy associated with HHV-6 and influenza virus infectionNaoyuki Tanuma, Japan

14:30-16:00 PLAtFoRM sessIon M4 Metabolic Chairs: Tatsuya Fujii (Japan) / Ingrid Tein (Canada)

C1-P1 FOXRED 1 mutations cause impaired mitochondrial complex I assembly and Leigh syndromeMasakazu Mimaki, Australia & Japan

33www.icnc2012.com


Mo

nD

AY28

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

C1-P2 A founder mutation in the GLRX5 gene is responsible for one form of atypical, late-onset non ketotic hyperglycinemiaSachin Gupta, Australia

C1-P3 Characteristic brain hypoperfusion by single photon emission computed tomography in children with diphenylarsenic acid intoxicationNobuaki Iwasaki, Japan

C1-P4 Biodistribution of native and complexed IGF-1 in transgenic CLN mice - novel candidate for treatment of infantile neuronal ceroid lipofuscinosis (INCL)Raili Riikonen, Finland

C1-P5 Chemical chaperone therapy for neuropathic Gaucher diseaseAya Narita, Japan

C1-P6 Against all odds: facing the challenges of Niemann-Pick type C treatmentCharles Lourenco, Brasil

14:30-16:00 PLAtFoRM sessIon M1+2 Movement disorders Chairs: Masaya Kubota (Japan) / Kate Sinclair (Australia)

D1-P1 Use dependent neuroplasticity in a randomized controlled trial of constraint induced movement therapy versus bimanual training for children with congenital hemiplegiaRoslyn Boyd, Australia

D1-P2 Does the absence of an abnormal imaging study define a specific cerebral palsy subtype?Michael Shevell, Canada

D1-P3 Pathophysiology of Tourette syndrome - premovement gating of somatosensory evoked potentialsKazue Kimura, Japan

D1-P4 Autoantibodies and their role in neuropsychiatric post-streptococcal sequelaeJonathan Zuccolo, USA

D1-P5 Determinants of functional abilities in Rett syndromeJenny Downs, Australia

D1-P6 The explanation for urinary dopamine excretion in patients with dopamine biosynthesis defectsMichèl Willemsen, The Netherlands

16:00-16:30 AFteRnoon teA AnD PosteRs exHIBItIon HALL

16:30-18:00 neURoCUtAneoUs AnD neURoGenetIC DIsoRDeRs Q1+2 new therapies in neurogenetic Cns disorders Chairs: John Lawson (Australia) / Anannit Visudtibhan (Thailand)

34 www.icnc2012.com


on

DAY

28tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

Advances in therapy of mTOR pathway in tuberous sclerosis complex David Franz, USA

New advances in therapies for neurofibromatosis 1 and 2 Kathryn North, Australia

Fragile X pathways and treatments Walter Kaufmann, USA

16:30-18:00 neURoGenetICs M3 new molecular technologies to discover disease-related or susceptibility genes Chairs: Ingrid Scheffer (Australia) / Shinichi Hirose (Japan)

New molecular technologies to discover genes for mental retardation Jozef Gecz, Australia

Progressive myoclonic epilepsies: impact of new molecular techniques Sam Berkovic, Australia

Update on susceptibility genes in childhood absence epilepsy Yuwu Jiang, China

16:30-18:30 MetABoLIC M4 Basic biology of organelles and their associated childhood neurological disease 1Chairs: Shinji Fushiki (Japan) / Rosemary Boustany (Lebanon)

Mitochondria: a diverse source of breakdowns in the brain’s power supply David Thorburn, Australia

Mitochondrial diseases Yuichi Goto, Japan

Biology of peroxisomes Bwee-Tien Poll-The, The Netherlands

Peroxisomal diseases Bwee-Tien Poll-The, The Netherlands

16:30-18:30 MoVeMent DIsoRDeRs M1+2 Diagnostic challenges: video sessions Chairs: Lillian Lee (Philippines) / Paddy Grattan-Smith (Australia)

Benign movement disorders in the first year of life Emilio Fernandez-Alvarez, Spain

Movement disorders in children: psychogenic or organic? Paddy Grattan-Smith, Australia

Dystonia: challenging learning cases Jonathan Mink, USA; Jean-Pierre Lin, UK

35www.icnc2012.com


Mo

nD

AY28

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

18:30-19:30 noVARtIs sYMPosIUM M3 expert exchange on selecting appropriate intervention for treatment of seGA

Welcome and introductionJohn Lawson, Australia

Therapeutic challenges in the management of TSCJohn Lawson, Australia

Clinical data on mTOR Inhibition for SEGA in patients with TSCSergiusz Jóźwiak, Poland

Individualizing patient care: panel debateJohn Lawson, Australia; Sergiusz Jóźwiak, Poland; Finbar O’Callaghan, UK

18:30-21:30 AoCnA nAtIonAL DeLeGAtes MeetInG M7+8

36 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNtU

esD

AY29

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

Tuesday 29th MayGREAT HALL Q1 & Q2 MEETING RM 3 MEETING RM 4 MEETING RM 1 & 2 MEETING RM 5 & 6 MEETING RM 7 & 8 PLAZA RMS

Breakfast Teaching 1

Eye movement disorders

07.20-08.20

Breakfast Symposium 1

Dravet syndrome or EFMR

07.20-08.20

Sheila Wallace Award LectureChallenges and

research priorities in management of

childhood acute coma in sub-Saharan Africa

08.30-09.10

PlenaryAutoimmune encephalitis09.15-10.00



EpilepsyEpileptic encephalo-pathies - improving

outcomes

CNS InfectionUpdate on endemic and epidemic CNS infection: a global

perspective

MetabolicUpdate on

Neurometabolic Therapies 2

Neurocritical CareAcquired brain injury

and outcomes



SIGEpiNet

12.45-13.30

SIG Health outcomes

Plaza Rm 1 & 212.45-13.45Parallel Sessions 13.30-14.30

Clinical Research Methodology

An approach to clinical research methodology

NeuroimagingNeuroimaging in

neurodegeneration

MetabolicUpdate in vitamin

responsive conditions



WorkshopNeurology of reflex

syncope Plaza Rm 1&214.30-18.00


16.10-16.30


EpilepsyEpilepsy diets: what

are the options?

CNS infectionEncephalitis

MetabolicBasic biology of

organelles and their associated childhood

neurological disease 2

Neurocritical CareNeuroprotection and hypothermia therapy

Close 18.00/18.30 ICNA Annual General Meeting

Plaza Rm 1&218.30-19.30

37www.icnc2012.com


tUes

DAY

29tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

tUesDAY 29tH MAY07:00-07:20 BReAKFAst FoR BReAKFAst sessIon AttenDees

07:20-08:20 BReAKFAst teACHInG sessIon 1 M3 Chair: Emilio Fernandez-Alvarez (Spain)

Eye movement disorders: a video approach Paddy Grattan-Smith, Australia

Categorisation of movement disorders Terence Sanger, USA

07:20-08:20 BReAKFAst sYMPosIUM 1 M4 Dravet syndrome or eFMR: what is the difference?Chair: Sameer Zuberi (UK)

SCN1A spectrumSameer Zuberi, UK

The girls’ only story Ingrid Scheffer, Australia

Can you tell the difference? Norimichi Higurashi, Japan

08:30-09:10 sHeILA WALLACe AWARD LeCtURe Q1+2 IntroductionCharles Newton, Kenya

Challenges and research priorities in management of childhood acute coma in sub-Saharan Africa Samson Gwer, Kenya

09:15-10.00 PLenARY LeCtURe Q1+2 IntroductionIngrid Tein, Canada

Autoimmune encephalitis Josep Dalmau, Spain & USA


10:30-12:30 ePILePsY Q1+2 epileptic encephalopathies- improving outcomesChairs: Simon Harvey (Australia) / Yoko Ohtsuka (Japan)

Defining the problem: evidence from clinical practice Sharon Whiting, Canada

New genetic insights into epileptic encephalopathies Sarah Weckhuysen, Belgium

38 www.icnc2012.com


esD

AY29

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

Pathogenesis of epileptic encephalopathy: insights from animal studies Rod Scott, UK

Epileptic encephalopathy; can we make a difference? Colin Ferrie, UK

10:30-12:30 Cns InFeCtIon M3 Update on endemic and epidemic Cns infection: a global perspectiveChairs: Marissa Lukban (Philippines) / Jo Wilmshurst (South Africa)

The effect of Plasmodium falciparum on the developing brain Charles Newton, Kenya

HIV encephalopathy and neurological complications Jo Wilmshurst, South Africa

CNS tuberculosis Johannes Schoeman, South Africa

Neurocysticercosis Pratibha Singhi, India

Viral CNS infections in African children Mac Mallewa, Malawi

10:30-12:30 MetABoLIC M4 Update on neurometabolic therapies 2Chairs: Cheuk-wing Fung (China) / Ingrid Tein (Canada)

Therapeutic strategies for antiquitin and PNPO defects Barbara Plecko, Austria

Creatine deficiency syndromes Sylvia Stockler, Canada

Chaperone therapy Yoshiuki Suzuki, Japan

Role of tetrahydrobiopterin (BH4) therapy in PKU Haruo Shintaku, Japan

10:30-12:30 neURoCRItICAL CARe M1+2 Acquired brain injury and outcomesChairs: Michael Johnston (USA) / Guillermo Agosta (Argentina)

An evidence based approach to head trauma: identification and early management of children at risk John Beca, New Zealand

New horizons in the management of acute neurological illness: an Asian intensive care perspective Sunit Singhi, India

39www.icnc2012.com


tUes

DAY

29tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

Traumatic brain injury and neurological outcomes Mohammed Jan, Saudi Arabia

Cognitive and social consequences of acquired brain injury in children Vicki Anderson, Australia


12:45-13:45 sPeCIAL InteRest GRoUP PLAZA 1+2Health and outcomes in children and young adults with neurological and developmental conditions Chair: Gabriel Ronen (USA)

Concepts and perspectives of ‘health’ and ‘health outcomes’ in young people with neurological and developmental conditionsGabriel Ronen, Canada

Viewing children with neurodevelopmental conditions through the WHO’s ICF lensOlaf Kraus de Camargo, Canada

Knowledge translation: accessing and using the best evidence to improve child and family outcomeIona Novak, Australia

Why do we need to train adult specialists to understand and accommodate the needs of people with childhood onset neurodevelopmental conditions?Bernard Dan, Belgium

The importance of studying populations with childhood onset neurodevelopmental conditions throughout their lifespanJenny Downs, Australia; Helen Leonard, Australia

12:45-13:30 sPeCIAL InteRest GRoUP M7+8An international collaboration to undertake clinical research in epilepsy: the epinet project Peter Bergin, New Zealand

13:30-14:30 CLInICAL ReseARCH MetHoDoLoGY Q1+2 An approach to clinical research methodologyChair: Madeleine Sosa (Philippines)

Invigorating clinical research. What are the keys to success? Sam Berkovic, Australia

13:30-14:30 neURoIMAGInG M3 neuroimaging in neurodegenerationChairs: Jun-ichi Takanashi (Japan) / Sakku Naidu (USA)

MRI in hereditary neurodegeneration/metabolic disease Meral Topcu, Turkey

40 www.icnc2012.com


esD

AY29

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

PET in neurodegeneration Harry Chugani, USA

H-MRS in neurodegeneration Jun-ichi Takanashi, Japan

13:30-14:30 MetABoLIC M4 Update in vitamin responsive conditions Chairs: Haruo Shintaku (Japan) / Barbara Plecko (Austria)

Vitamin responsive neurological conditions in children Mohammed Jan, Saudi Arabia

What is the spectrum of pyridoxine dependent CNS syndromes? Peter Baxter, UK

13:30-14:30 CHALLenGes In CHILD neURoLoGY 1 M1+2 Chairs: Akemi Tomoda (Japan) / Rob Smith (Australia)

An approach to psychogenic disorders Paddy Grattan-Smith, Australia

Chronic fatigue syndrome and school refusal Teruhisa Miike, Japan

14:30-16:00 PLAtFoRM sessIon Q1+2 epilepsy Chairs: Yi Wang (China) / Venkateswaran Ramesh (UK)

A2-P1 Genetic abnormality in SCN9A: cause and modifier of Dravet syndromeSu-Kyeong Hwang, Japan

A2-P2 Use of the modified Atkins diet for the treatment of refractory childhood epilepsy: a randomized controlled trialSuvasini Sharma, India

A2-P3 Verbal memory in children with temporal lobe epilepsy: evidence of double dissociation and differential impact on the development of literacy skillsSuncica Lah, Australia

A2-P4 Effects of hyperthermia on novel HCN2 mutant channels found in febrile seizure patientsYuki Nakamura, Japan

A2-P5 Seizure severity and verbal accelerated long-term forgetting in children with idiopathic generalised epilepsyMichael Gascoigne, Australia

A2-P6 New therapeutic possibilities in epilepsy in the first year of life caused by congenital and perinatal cytomegalovirus infectionDorota Dunin-Wasowicz, Poland

41www.icnc2012.com


tUes

DAY

29tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

14:30-16:00 PLAtFoRM sessIon M3 Development, cognition and psychiatry 1Chairs: Andre Venter (South Africa) / Kevin Collins (Australia)

B2-P1 Executive functioning in children and adolescents with congenital hemiplegiaHarriet Bodimeade, Australia

B2-P2 The syndrome of infantile-onset saccade initiation delay (congenital ocular motor apraxia)Michael Salman, Canada

B2-P3 Polymicrogyria in association with abnormalities in basal ganglia, corpus callosum, pons and cerebellar vermis points to mutations in TUBB2BAnna Jansen, Belgium

B2-P4 The CDKL5 disorder: a new cause of early-onset encephalopathyStephanie Fehr, Australia

B2-P5 14q12 microdeletion: a Rett syndrome – like phenotypeCarolyn Ellaway, Australia

B2-P6 Epilepsy and subcortical band heterotopia without DCX/LIS1 gene mutationsEva Andermann, Canada

14:30-16:00 PLAtFoRM sessIon M4 neurocutaneous and neurogenetic disordersChairs: Elizabeth Palines (Philippines) / Kathryn North (Australia)

C2-P1 Exome-sequencing identifies a mutation in the ASNS gene as a cause of progressive microcephaly and brain atrophy in Iranian JewsBruria Ben-Zeev, Israel

C2-P2 Molecular genetic analysis of autosomal recessive microcephaly by whole-exome sequencingGaneshwaran Mochida, USA

C2-P3 Chromosomal microarray analysis in children with epilepsy and neuro-developmental disordersMajed Dasouki, USA

C2-P4 Identification and functional studies of MLC1 mutations in Chinese patients with megalencephalic leukoencephalopathy with subcortical cystsJing-Min Wang, China

C2-P5 Australian experience of mTor inhibitors for subependymal giant cell astrocytomas and refractory seizures in patients with tuberous sclerosis complexMichael Cardamone, Australia

42 www.icnc2012.com


esD

AY29

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

C2-P6 Proteolipid protein 1 (PLP1) gene mutation analysis in 44 Chinese patients with Pelizaeus-Merzbacher disease and in 5 prenatal fetuses of PMD probandsJingmin Wang, China

C2-P7 National survey of Cockayne syndrome in Japan: clinical course and prognostic factorsSayaka Ohta, Japan

14:30-16:00 PLAtFoRM sessIon M1+2 Headache, neurosurgery and neuroimagingChairs: Martha Bolaños (Philippines) / Kenneth Mack (USA)

D2-P1 MRI of developmental brain anomalies in bilateral posterior periventricular nodular heterotopiaSimone Mandelstam, Australia

D2-P2 The effect of disulfiram in mouse model of Menkes diseaseTaisuke Takeda, Japan

D2-P3 Conflict processing in learning disability in children: an fMRI studyMarja Balk, Finland

D2-P4 Everolimus in the treatment of subependymal giant cell astrocytomas (SEGAs) associated with tuberous sclerosis complex (TSC): the EXIST-1 trialSergiusz Jozwiak, Poland

D2-P5 Long-term safety and efficacy of everolimus in subependymal giant cell astrocytomas in patients with tuberous sclerosis complexDarcy Krueger, USA

D2-P6 Efficacy and safety of cinnarizine compared with propranolol in the prophylaxis of childhood migraine headacheMahmoud Reza Ashrafi, Iran

14:30-18:00 WoRKsHoP PLAZA 1+2 neurology of reflex syncopesChair: Rob Rust (USA)

Introduction and overview of reflex syncopes in newborns, infants and children, with video-demonstrations John Stephenson, UK

Breath-holding spells in children Francis DiMario, USA

Arrest of the cerebral circulation in adults David Robertson, USA

Why is the semiology of syncope so poorly recognized? John Stephenson, UK

43www.icnc2012.com


tUes

DAY

29tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

What is the future for implantable recorders? Satish Raj, USA

What is muscle sympathetic nerve activity (MSNA) doing at the onset of syncope? David Jardine, New Zealand

Lack of sympathetic withdrawal in vasovagal syncope Gautam Vaddadi, Australia

Problems in evaluating the sympathetic nervous system Vaughan Macefield, Australia

Genetic causes of orthostatic intolerance David Robertson, USA

Cardiac and respiratory syncopes in SCN9A-mutated PEPD Colin Ferrie, UK

More general lessons from the syncopes of PEPD? John Stephenson, UK; Speaker panel


16:30-18:30 ePILePsY Q1+2epilepsy diets: what are the options?Chairs: Ki Joong Kim (Korea) / Sophie Calvert (Australia)

Ketogenic diet Roberto Caraballo, Argentina

PUFA enriched diet therapy Hoon-Chul Kang, Korea

Modified Atkins Sophie Calvert, Australia

Low GI diet Helen Cross, UK

16:30-18:30 Cns InFeCtIon M3 encephalitis Chairs: Russell Dale (Australia) / Masashi Mizuguchi (Japan)

Viral and autoimmune encephalitis: phenotypes and syndromes Russell Dale, Australia

Acute encephalitis with refractory, repetitive partial seizures (AERRPS) and limbic encephalitis in Japan Hiroshi Sakuma, Japan

Mild encephalitis and encephalopathy with a reversible splenial lesion (MERS) Jun-ichi Takanashi, Japan

44 www.icnc2012.com


esD

AY29

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

Immunogenetics can define vulnerability: lessons from herpes simplex encephalitisMarc Tardieu, France

16:30-18:30 MetABoLIC M4 Basic biology of organelles and their associated childhood neurological disease 2Chairs: Hsiu-Fen Lee (Taiwan) / Bridget Wilcken (Australia)

Biology of fatty acid oxidation Niels Gregersen, Denmark

Fatty acid oxidation disorders Ingrid Tein, Canada

Biology of lysosomes Rosemary Boustany, Lebanon

Lysosomal disorders Yoshiuki Suzuki, Japan

16:30-18:00 neURoCRItICAL CARe M1+2 neuroprotection and hypothermia therapyChairs: Pi-Chuan Fan (Taiwan) / Michael Johnston (USA)

Neuroprotection and neurointensive care at a molecular level Michael Johnston, USA

Hypothermia therapy in acute brain injury in children John Beca, New Zealand

Head cooling in neonatal hypoxic ischaemic encephalopathy: animal models and clinical trialsAlistair Gunn, New Zealand

18:30-19:30 InteRnAtIonAL CHILD neURoLoGY AssoCIAtIon GeneRAL MeetInG PLAZA 1+2

© P

nies

en | D

ream

stim

e.co

m

46 www.icnc2012.com


eDn

esD

AY30

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

Wednesday 30th MayGREAT HALL Q1 & Q2 MEETING RM 3 MEETING RM 4 MEETING RM 1 & 2 MEETING RM 5 & 6 MEETING RM 7 & 8 PLAZA RMS


EEG07.20-08.20

Breakfast Symposium 2Cerebral palsy07.20-08.20

Breakfast Symposium 3Cerebral palsy07.20-08.20

PlenaryNew and exciting

imaging techniques that help to diagnose

and increase the understanding of

congenital and acquired brain

disorders 08.30-09.10

PlenaryTiming issues in

perinatal brain injury: impact on therapy

09.15-10.00



Cerebral PalsyCutting edge management

Challenges in Child Neurology 2Role of child neurology in

overwhelming natural disasteres

NeuroimmunologyCNS demyelination and demyelination

mimics

Neurocritical CareDisorders of

consciousness



SIG Headache

Meeting Rm 7&812.45-13.45

ICNA CODPlaza Rm 1&212.45-13.45


Cerebral PalsyGenetics and antecedents

NeuroimagingDiffusion Tensor

Imaging

NeuroimmunologyCerebral vasculitis: the diagnostic challenge

NeurogeneticsUse of copy number

variant (CNV) technologies


WorkshopPeripheral Neuropathy

and Neuronopathy 14.30-17.00


16.10-16.30


Cerebral palsyMeet the experts -

technology

EpilepsyUnusual paroxysmal

events in child neurology: video

sessions

NeuroimmunologyThe 2nd International

focus group on paediatric myasthenia

gravis

Neurogenetics Neuronal brain iron accumulation (NBIA)

Close 18.00/18.30 AOCNA General Assembly

Plaza Rm 1&218.30-19.30

47www.icnc2012.com


WeD

nes

DAY

30tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

WeDnesDAY 30tH MAY07:00 - 07:20 BReAKFAst FoR BReAKFAst sessIon AttenDees

07:20-08:20 BReAKFAst teACHInG sessIon 2 M3 Chair: Steve Malone (Australia)

Non-epileptic paroxysmal events: case and video based approach Steve Malone, Australia

EEG tips and tricks John Lawson, Australia

07:20-08:20 BReAKFAst sYMPosIUM 2 M4 Cerebral palsy: international perspectives Chair: Nadia Badawi (Australia)

Neurorehabilitation in the developing world: limits within boundaries Pratibha Singhi, India

An approach to cerebral palsy in Africa Angelina Kokooza, Uganda

Management of cerebral palsy in the Middle East Susan Waller, UAE

07:20-08:20 BReAKFAst sYMPosIUM 3 M1+2 Canadian Cerebral Palsy Demonstration Project A model for collaborative research in the 21st century Michael Shevell & Annette Majnemer, Canada

08:30-09:10 PLenARY LeCtURe Q1+2 (stReAMInG to M3)IntroductionHarry Chugani, USA

New and exciting imaging techniques that help to diagnose and increase the understanding of congenital and acquired brain disorders James Barkovich, USA

09:15-10.00 PLenARY LeCtURe Q1+2 (stReAMInG to M3)IntroductionHarry Chugani, USA

Timing issues in perinatal brain injury: impact on therapy Donna Ferriero, USA


10:30-12:30 CeReBRAL PALsY Q1+2 Cutting edge management Chair: Adam Scheinberg (Australia)

48 www.icnc2012.com


eDn

esD

AY30

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

AusACPDM international keynote addressUnderstanding dystoniaTerence Sanger, USA

ICnA keynote addressDeep brain stimulation for cerebral palsy: current experience and future challengesJean-Pierre Lin, UK

AusACPDM Asia-Pacific keynote addressThe elephant in the clinic: gross motor function of children with cerebral palsyKerr Graham, Australia

10:30-12:30 CHALLenGes In CHILD neURoLoGY 2 M3 Role of child neurology in overwhelming natural disastersChairs: Yoichi Sakakihara (Japan) / Paolo Curatolo (Italy)

Health hazards in devastating earthquake and tsunami disasters, March 2011, JapanKazuie Iinuma, Japan

Radiation hazards in children (lessons from Chernobyl, Three Mile Island and Fukushima) Shinji Fushiki, Japan

Post-traumatic stress disorders & mental health care provision (lessons from the Hanshin earthquake, Kobe, 1995) Satoshi Takada, Japan

Effects of natural disasters on neurodevelopment and evidence of resilience in children in Bangladesh, a disaster-prone country Naila Khan, Bangladesh

Experience of a child neurologist during disasters in a developing country Kyaw Linn, Myanmar

Psychological and neurodevelopmental problems in children after a massive earthquake in Taiwan, 1999: a long-term follow-up Wun-Tsong Chaou, Taiwan

10:30-12:30 neURoIMMUnoLoGY M4 Cns demyelination and demyelination mimics Chairs: Jean Marie Ahorro (Philippines) / Andrew Kornberg (Australia)

CNS demyelinating disorders of autoimmune aetiology Banu Anlar, Turkey

Demyelinating disease in Korean children Jong Hee Chae, Korea

New and old therapies in CNS demyelination and multiple sclerosis Angelo Ghezzi, Italy

49www.icnc2012.com


WeD

nes

DAY

30tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

Haemophagocytic lymphohistiocytosis Marc Tardieu, France

10:30-12:30 neURoCRItICAL CARe M1+2Disorders of consciousness Chairs: Samson Gwer (Kenya) / Sunit Singhi (India)

Evaluation of the comatose child Fenella Kirkham, UK

Acute non-traumatic encephalopathy in children in Sub-Saharan Africa Richard Idro, Uganda

The vegetative and minimally conscious state Stephen Ashwal, USA

Brain deathStephen Ashwal, USA


12:45-13:45 sPeCIAL InteRest GRoUP M7+8 HeadacheICHD2 and primary headache disorders (including TAC) in childrenMV Francis, India

Explicit and appendix criteria - focus on future researchMV Francis, India

Ominous headaches and benign neuroophthalmological manifestations in children - indications for neuroimagingMV Francis, India

Co-morbidities, cranial neuralgias and other rare headaches in the pediatric age groupMV Francis, India

13:30-14:30 CeReBRAL PALsY Q1+2 Genetics and antecedents Chair: Eve Blair (Australia)

AusACPDM Presidential guest lecture Cerebral Palsy - at last its time to talk about prevention, and maybe even cure?Nadia Badawi, Australia

AusACPDM Dinah Reddihough oration Cerebral Palsy - is it in your genes? Genetic susceptibility and environmental risk factorsAlastair MacLennan, Australia

50 www.icnc2012.com


eDn

esD

AY30

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

13:30-14:30 neURoIMAGInG M3 Diffusion tensor imaging Chairs: Jun-ichi Takanashi (Japan) / Harry Chugani (USA)

Principles of diffusion tensor imaging and overview James Barkovich, USA

DTI in autism Diane Chugani, USA

DTI in neurodevelopmental disorders Harry Chugani, USA

13:30-14:30 neURoIMMUnoLoGY M4 Cerebral vasculitis, the diagnostic challenge Chairs: Vijeya Ganesan (UK) / Banu Anlar (Turkey)

Overview, pathology and treatment of cerebral vasculitis Susanne Benseler, Canada

Imaging the vessels in cerebral vasculitis: MR angiography versus conventional angiography Vijeya Ganesan, UK

13:30-14:30 neURoGenetICs M1+2 Use of copy number variant (CnV) technologies Chairs: Yu-wu Jiang (China) / Ingrid Scheffer (Australia)

CNV in epilepsy, autistic spectrum disorders and intellectual disability Heather Mefford, USA

CGH microarray in child neurology: providing answers or creating more questions?Feng Zhang, China

14:30-16:00 PLAtFoRM sessIon Q1+2 Cerebral Palsy Chairs: Geoff Wallace (Australia) / Leanne Johnston (Australia)

AusACPDM Platforms – Antecedents of cerebral palsy in children born at or near term

A3-P1 A systematic review of aetiological risk factors for children with cerebral palsy born at termSarah McIntyre, Australia

A3-P2 Cerebral palsy in term and late preterm born singletons and macroscopically identified placental infarctionsEve Blair, Australia

51www.icnc2012.com


WeD

nes

DAY

30tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

A3-P3 Children with cerebral palsy and periventricular white matter injury: do children born after 34 weeks gestation have better functional outcomes?Melinda Randall, Australia

ICnA Platforms

A3-P4 The relationship between brain structure and gait patterns in children with congenital hemiplegiaRoslyn Boyd, Australia

A3-P5 Term neonatal encephalopathy antecedent cerebral palsy: a population based analysisMichael Shevell, Canada

A3-P6 Brain stimulation and constraint for perinatal stroke hemiparesis: interim safety and feasibility in the PLASTIC CHAMPS trialAdam Kirton, Canada

14:30-16:00 PLAtFoRM sessIon M3 epilepsy Chairs: Lieven Lagae (Belgium) / Ahmed Raouf Ibrahim (Egypt)

B3-P1 Successful use of fenfluramine as add-on treatment in Dravet syndromeBerten Ceulemans, Belgium

B3-P2 Automated markerless video seizure detectionDerrick Chan, Singapore

B3-P3 Analysis of neuroscores assigned prospectively to children with Sturge-Weber syndrome receiving low-dose aspirin between 2005 and 2011Anne Comi, USA

B3-P4 Diffusion tensor imaging in cryptogenic West syndrome: tract-based spatial statistics analysisJun Natsume, Japan

B3-P5 Progressive gait deterioration in adolescents with Dravet syndromeJill Rodda, Australia

B3-P6 Paeoniflorin suppresses experimental febrile seizures and inhibits glutamate-mediated neuronal excitability and neuronal deathHitomi Hino, Japan

14:30-16:00 PLAtFoRM sessIon M4 neuroimmunology Chairs: Daniela Pohl (Canada) / Ian Andrews (Australia)

C3-P1 Prognostic factors in paediatric acute myelitisBernard Echenne, France

52 www.icnc2012.com


eDn

esD

AY30

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

C3-P2 Safety and efficacy of subcutaneous interferon beta-1a in children and adolescents with multiple sclerosis: an international retrospective cohort studyDaniela Pohl, Canada

C3-P3 Paediatric autoimmune encephalitis: evaluation of clinical features, laboratory investigations and outcomeYael Hacohen, UK

C3-P4 Acute haemorrhagic leucoencephalopathy secondary to H1N1Kate Riney, Australia

C3-P5 The aetiology and outcome of childhood encephalitis: a 13 year retrospective Australian cohortSekhar Pillai, Australia

C3-P6 Immunohistochemistry by patient sera in subacute and focal encephalopathy in JapanMasaharu Hayashi, Japan

14:30-16:00 PLAtFoRM sessIon M1+2 Development, cognition and psychiatry 2 Chairs: Marilyn Ortiz (Philippines) / Richard Webster (Australia)

D3-P1 Neurodevelopmental outcome of term infants following major surgery in infancyKaren Walker, Australia

D3-P2 The international Rett syndrome database, InterRett: an exemplary model for rare disease researchAlison Anderson, Australia

D3-P3 Cognitive-motivational deficits in attention-deficit hyperactivity disorder: a diagnostic concernRashmi Gupta, India

D3-P4 How does genotype influence the early clinical presentation in Rett syndrome?Jenny Downs, Australia

D3-P5 Bimanual coordination in young children born preterm: effects of white matter injuryDeirdre Birtles, UK

D3-P6 An analysis of communication abilities in girls and women with Rett syndromeAnna Urbanowicz, Australia

14:30-17:00 WoRKsHoP PLAZA 1+2 Peripheral neuropathy and neuronopathy: diagnostic approaches and pathophysiological insightsChair: Michelle Farrar (Australia)

53www.icnc2012.com


WeD

nes

DAY

30tH

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

Peripheral nerve maturation in humans: new insights, diagnostic and pathophysiological considerations Michelle Farrar, Australia

Hereditary motor neuropathy Steve Vucic, Australia

Spinal muscular atrophyMichelle Farrar, Australia

Update in clinical research in Charcot Marie Tooth disease Eppie Yiu, Australia

Biomarkers for treatment Cindy Lin, Australia


16:30-17:30 CeReBRAL PALsY Q1+2 Meet the experts - technologyChair: Sarah Love (Australia)

Assistive technology, environmental controls and customized technologies for children with developmental disabilities Martin Ferguson-Pell, USA

Integrating innovative technology to enhance outcomes for children with cerebral palsy Debra Gaebla-Spira, USA

16:30-18:30 ePILePsY M3 Unusual paroxysmal events in child neurology: video sessions Chairs: Masaya Segawa (Japan) / Sameer Zuberi (UK)

Is it a seizure or a movement disorder? Sameer Zuberi, UK

Neonates - is it a seizure? Annie Bye, Australia

Absences - can you pick the difference? Lynette Sadleir, New Zealand

16:30-18:30 neURoIMMUnoLoGY M4 the 2nd International focus group on paediatric myasthenia gravisChair: Virginia Wong (China)

MuSK-related myaesthenia gravis in infants and children Nancy Kuntz, USA

Myaesthenia gravis worldwide Angela Vincent, UK

54 www.icnc2012.com


eDn

esD

AY30

tH M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

Clinical characteristics and management of myaesthenia gravis in ChinaHui Xiong, China

Paediatric myaesthenia gravis - the Canadian perspective Jiri Vajsar, Canada

International myaesthenia gravis registry Virginia Wong, Hong Kong

16:30-18:00 neURoGenetICs M1+2 neuronal brain iron accumulation (nBIA) Chair: Susan Hayflick (USA)

Overview and update of NBIA: PKAN and other syndromes Susan Hayflick, USA

NBIA: a Chinese experience Ye Wu, China

Emerging therapies in NBIA Penny Hogarth, USA

18:30-19:30 AsIAn AnD oCeAnIAn CHILD neURoLoGY AssoCIAtIon GeneRAL AsseMBLY PLAZA 1+2

© C

loud

ia N

ewla

nd | D

ream

stim

e.co

m

56 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNtH

URs

DAY

31st

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

Thursday 31st MayGREAT HALL Q1 & Q2 MEETING RM 3 MEETING RM 4 MEETING RM 1 & 2 MEETING RM 5 & 6 MEETING RM 7 & 8 PLAZA RMS

Breakfast Symposium 4

Cerebellar disorders07.20-08.20


Epilepsy07.20-08.20

PlenaryThe potential of stem

cell therapy in 21st century paediatric

neurology 08.30-09.10

PlenaryPediatric stroke

treatment - balancing risks and benefits

09.15-10.00



Muscle & NerveUpdate in myopathy

StrokeChildhood arterial ischaemic stroke


Neuro-developmental outcome:

international perspectives

Neonatal NeurologyUpdates and insights

into the neonatal brain



SIG Vigabatrin12.45-13.15

SIG Stroke

Plaza Rm 6&712.45-13.45


NeurogeneticsUpdate in genetics of

neonatal seizures

NeuroimagingNeuroimaging of neurometabolic

disease


Treatable causes of intellectual disability



SIG Cerebellar

14.30-15.30

WorkshopAutoantibody mediated CNS

disorders Plaza Rm 6&714.30-17.00


16.10-16.30


EpilepsyGLUT1 deficiency: a

moving target

StrokeDiagnostic dilemmas in childhood stroke

Muscle & NerveSpinal muscular

atrophy

Neonatal NeurologyBringing neurology

into the neonatal intensive care unit African Child

Neurology Association

Meeting18.00-19.00

ANZCNS Members Meeting

Plaza Rm 6&718.00-19.00

Close 18.00/18.30

Gala Dinner 19.00-23.00

57www.icnc2012.com


tHU

RsD

AY31

st M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

tHURsDAY 31st MAY07:00 - 07:20 BReAKFAst FoR BReAKFAst sessIon AttenDees

07:20-08:20 BReAKFAst sYMPosIUM 4 M3 Cerebellar disorders Chairs: Michael Salman (Canada) / Masaharu Hayashi (Japan)

Practical approach & clinical pearls in paediatric ataxia Michael Salman, Canada

Differential diagnosis of paediatric cerebellar atrophy Andrea Poretti, USA

Approach to genetic diagnosis of childhood cerebellar atrophy Grace Yoon, Canada

07:20-08:20 BReAKFAst teACHInG sessIon 3 M4 Chair: Sophia Varadkar (UK)

Seizure semiology and ILAE classification Kate Riney, Australia; Sophia Varadkar, UK

08:30-09:10 PLenARY LeCtURe Q1+2 IntroductionYoichi Sakakihara, Japan

The potential of stem cell therapy in 21st century paediatric neurology Hideyuki Okano, Japan

09:15-10.00 PLenARY LeCtURe Q1+2 IntroductionYoichi Sakakihara, Japan

Pediatric stroke treatment: balancing risks and benefits Gabrielle de Veber, Canada


10:30-12:30 MUsCLe AnD neRVe Q1+2 Update in myopathy Chairs: Makiko Osawa (Japan) / Monique Ryan (Australia)

Advances in the muscular dystrophies Kathryn North, Australia

Neuromuscular disease of autoimmune origin Angela Vincent, UK

Metabolic myopathies Ichizo Nishino, Japan

Unusual muscle disease in children Haluk Topaloglou, Turkey

58 www.icnc2012.com


URs

DAY

31st

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

10:30-12:30 stRoKe M3 Childhood arterial ischaemic stroke Chairs: Yi-Fang Tu (Taiwan) / Gabrielle deVeber (Canada)

Early recognition and stroke mimics Kees Braun, Netherlands

Risk factors: an international perspective Mark Mackay, Australia

Arteriopathy in childhood AIS: classification and evolution Guillaume Sebire, Canada

Arteriopathy: disease mechanisms Vijeya Ganesan, UK

10:30-12:30 DeVeLoPMent AnD CoGnItIon M4 neurodevelopmental outcome: international perspectivesChairs: Ying-Chao Chang (Taiwan) / Charles Newton (Kenya)

Tools, procedures and techniques for identifying developmental impairments in very young children in countries with limited resources Naila Khan, Bangladesh

Neuropsychological tools for detecting early brain insult and later sequelae Faraneh Vargha-Khadem, UK

Neurodevelopmental outcomes following CNS infection in African children Mike Kihara, Kenya

Cognitive and developmental comorbidity in paediatric epilepsy Marilisa Guerreiro, Brazil

10:30-12:30 neonAtAL neURoLoGY M1+2 Updates and insights into the neonatal brain Chairs: Lung-Chang Lin (Taiwan) / Linda de Vries (The Netherlands)

Developing connectivity and tractography in the neonatal brain Ellen Grant, USA

Early development of EEG activity: structure versus function Sampsa Vanhatalo, Finland

Aetiopathogenesis and prognosis of antenatally detected CNS anomalies Tally Lerman-Sagie, Israel

Neuroprotective strategies in neonatal brain injury Donna Ferriero, USA

59www.icnc2012.com


tHU

RsD

AY31

st M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e


12:45-13:15 sPeCIAL InteRest GRoUP M7+8Does vigabatrin treatment for infantile spasms bring visual field defects? Raili Riikonen, Finland

12:45-13:45 sPeCIAL InteRest GRoUP PLAZA 6+7the International Pediatric stroke study informal meeting Mark Mackay, Australia; Gabrielle de Veber, Canada

13:30-14:30 neURoGenetICs Q1+2 Update in genetics of neonatal seizures Chairs: Hitoshi Yamamoto (Japan) / Orvar Eeg-Olofsson (Sweden)

Genetics of benign neonatal seizures Shinichi Hirose, Japan

New genetic discoveries in malignant forms of neonatal seizures Mitsuhiro Kato, Japan

13:30-14:30 neURoIMAGInG M3 neuroimaging of neurometabolic disease Chair: Meral Topcu (Turkey)

Neuroimaging in novel conditions with and without known metabolic disorders Sakku Naidu, USA

13:30-14:30 DeVeLoPMent AnD CoGnItIon M4 treatable causes of intellectual disability Chairs: Michael Shevell (Canada) / Rosemary Marks (New Zealand)

A diagnostic protocol to detect treatable cases of intellectual disability Clara van Karnebeek, Canada; Sylvia Stockler, Canada

13:30-14:30 CHALLenGes In CHILD neURoLoGY 3 M1+2 Chairs: Ian Wilkinson (Australia) / Sergio Rosemberg (Brasil)

An approach to chronic daily headache Kenneth Mack, USA

Daytime sleepiness and its impact upon performance Suresh Kotagal, USA

14:30-16:00 PLAtFoRM sessIon Q1+2 epilepsy Chairs: Claire Spooner (New Zealand) / Deepak Gill (Australia)

A4-P1 A five-year review of childhood deaths due to SUDEP in QueenslandDamian Clark, Australia

60 www.icnc2012.com


URs

DAY

31st

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

A4-P2 WITHDRAWN(Varda Gross-Tsur, Israel)

A4-P3 CSF study of cation-chloride cotransporters may improve rational treatment of early seizuresSofia Duarte, Portugal

A4-P4 Vitamin D levels in a hospital based population of children on long-term antiepileptic drugsChoong Yi Fong, Australia

A4-P5 Polymicrogyria: clinical phenotypes, copy number variations, and evidence for a novel locus narrowed to 2p16.1-p16.3Dina Amrom, Canada

A4-P6 Clinical features and surgical outcome of hemimegalencephaly in Saudi ArabiaSuad Al Yamani, Saudi Arabia

14:30-16:00 PLAtFoRM sessIon M3 neurocritical care and stroke Chairs: Hugo Arroyo (Argentina) / Mark Mackay (Australia)

B4-P1 The characteristics of post-traumatic headaches in children following mild traumatic brain injury and their response to treatmentKaren Barlow, Canada

B4-P2 Predictors of recurrence after childhood arterial ischaemic strokeJoanne Ng, UK

B4-P3 Comparison of CNS vasculitis in children and adults: is this the same disease entity?Susanne Benseler, Canada

B4-P4 The relationship between early neurological impairment, stroke characteristics and functional outcome at six and twelve months following paediatric strokeAnne Gordon, Australia & UK

B4-P5 Brain T2-weighted signal intensity ratio in children with sickle cell disease with and without strokeJoseph Collinson, UK

B4-P6 A prediction rule for post-concussion syndrome in paediatric mild traumatic brain injuryKaren Barlow, Canada

14:30-16:00 PLAtFoRM sessIon M4 Muscle and nerve Chairs: Anita Cairns (Australia) / Monique Ryan (Australia)

C4-P1 Charcot-Marie-Tooth disease Paediatric Scale: validation of an outcome measure of disabilityJoshua Burns, Australia

61www.icnc2012.com


tHU

RsD

AY31

st M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

C4-P2 Test-retest reliability and normative data of the six-minute walk test in healthy boys aged 5 to12 yearsGunnar Buyse, Belgium

C4-P3 Microarray testing for developmental delay reveals an expanded clinical spectrum of dystrophinopathiesKatherine Howell, Australia

C4-P4 Novel collagen VI mutation identified in Ullrich congenital muscular dystrophy patients in ChinaHui Xiong, China

C4-P5 Congenital myopathies: a clinicopathological study of 45 casesSheffali Gulati, India

C4-P6 X-linked dominant Charcot-Marie-Tooth disease: evidence for further genetic heterogeneityEppie Yiu, Australia

14:30-16:00 PLAtFoRM sessIon M1+2 Fetal and neonatal neurology Chairs: Cynthia Sharpe (New Zealand) / Lakshmi Nagarajan (Australia)

D4-P1 Pathogenesis of idiopathic congenital ptosisHarvey Sarnat, Canada

D4-P2 The optimal EEG monitoring window for seizure identification in newborns with hypoxic ischemic encephalopathy in the era of therapeutic hypothermiaNiamh Lynch, Ireland

D4-P3 Protective effect of thyroxine on periventricular leukomalacia in the immature rat brainPi-Lien Hung, Taiwan

D4-P4 Relationship between neonatal magnetic resonance imaging and gross motor function in children with neonatal encephalopathy and cerebral palsyAndrea Guzzetta, Australia

D4-P5 Automated grading of the EEG in full-term neonates with hypoxic ischemic encephalopathyNathan Stevenson, Ireland

D4-P6 Massaging babies’ brain: effects of preterm infant massage on the maturation of brain activityAndrea Guzzetta, Italy

14:30-15:30 sPeCIAL InteRest GRoUP M7+8Paediatric Cerebellar Disorders Focus Group Chair: Michael Salman (Canada)

62 www.icnc2012.com


URs

DAY

31st

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

Epidemiological and classification challenges in chronic ataxia and cerebellar disorders in childhoodMichael Salman, Canada

Impact of cerebellar malformations on cerebral developmentAndrea Poretti, USA

Advances in genetic technologies for the diagnosis of cerebellar disordersGrace Yoon, Canada

14:30-17:00 WoRKsHoP PLAZA 6+7 Autoantibody mediated Cns disorders Chair: Russell Dale (Australia)

Autoantibody assays and pathogenic mechanisms Angela Vincent, UK

NMDAR and VGKC encephalitis in children Angela Vincent, UK

Autoimmune movement disorders Russell Dale, Australia

Autoantibodies in epilepsy and limbic encephalitis Yukitoshi Takahashi, Japan

Myelin oligodendrocyte glycoprotein antibodies in CNS demyelination Fabienne Brilot, Australia

Rare and unusual putative autoimmune CNS disorders Rob Rust, USA


16:30-18:00 ePILePsY Q1+2 GLUt1 deficiency: a moving target Chairs: Jiong Qin (China) / Helen Cross (UK)

GLUT1 epilepsies Ingrid Scheffer, Australia

GLUT1 functional studies Steve Petrou, Australia

GLUT1 ketogenic diet and outcome Carla Marini, Italy

16:30-18:30 stRoKe M3 Diagnostic dilemmas in childhood stroke Chair: Vijeya Ganesan (UK) / Mark Mackay (Australia)

Diagnostic dilemmas in childhood stroke: a case based approach Panel: Mark Mackay (Australia), Gabrielle de Veber (Canada), Fenella Kirkham (UK),

63www.icnc2012.com


tHU

RsD

AY31

st M

AYsC

Ien

tIFI

CPR

oG

RA

MM

e

Finbar O’Callaghan (UK), Pratibha Singhi (India), Guillaume Sebire (Canada), Kees Braun (Netherlands)

16:30-18:30 MUsCLe AnD neRVe M4 spinal muscular atrophy Chairs: Haluk Topaloglou (Turkey) / Michelle Farrar (Australia)

Clinical aspects and genetic updates in SMA John Bodensteiner, USA

Clinical trials in Taiwanese children with SMA Yah-Jyh Jong, Taiwan

Type 1 SMA and palliative care John Collins, Australia

Neurobiological updates and future directions in SMA Gyula Acsadi, USA

16:30-18:30 neonAtAL neURoLoGY M1+2 Bringing neurology into the neonatal intensive care unitChair: Paul Colditz (Australia)

Introduction: what are the needs of the neonatologist, baby and family?Paul Colditz, Australia

What should the paediatric neurologist bring into the NICU now and in the future?Donna Ferriero, USA

Suggestions for a ‘best practice’ modelPanel discussion

The Dutch experience of bringing neurology into the NICU and the benefits derivedLinda de Vries, The Netherlands,

The neonatal neurological examination - how can we standardise?Donna Ferriero, USA; Linda de Vries, The Netherlands

Reflections from a neonatologist with aEEG experienceLena Hellstrom-Westas, Sweden

What can neurophysiology offer neonatology?Geraldine Boylan, Ireland

Current status in JapanAkihisa Okumura, Japan

The way forward in Japan and suggestions for an international ‘best practice’ planTetsuo Kubota, Japan

64 www.icnc2012.com


URs

DAY

31st

MAY

sCIe

ntI

FIC

PRo

GR

AM

Me

Suggestions for an international ‘best practice’ planPanel discussion

18:00-19:00 AUstRALIA AnD neW ZeALAnD CHILD neURoLoGY soCIetY MeMBeRs MeetInG PLAZA 6+7

18:00-19:00 AFRICAn CHILD neURoLoGY AssoCIAtIon MeetInG M5+6

19:00-23:00 ICnC/AoCCn 2012 GALA DInneR PLAZA BALLRooM

© R

obyn

Mac

kenz

ie | D

ream

stim

e.co

m

66 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNFR

IDAY

1st

JUn

esC

Ien

tIFI

CPR

oG

RA

MM

e

Friday 1st JuneGREAT HALL Q1 & Q2 MEETING RM 3 MEETING RM 4 MEETING RM 1 & 2 MEETING RM 5 & 6 MEETING RM 7 & 8 PLAZA RMS


Parasomnias & sleep disorders

07.20-08.20

Frank Ford Memorial Award

LectureAustralasian

contributions to child neurology

08.30-09.10

PlenaryUpdate on congential

myopathies09.15-10.00

Morning Tea 10.00-10.30

Poster & Platform Awards Exhibition Hall 10.15-10.30



Neurobiological basis of autism

StrokeSubtypes of

childhood stroke

Muscle & NerveUpdate in peripheral

neuropathy

Neonatal Neurology

Neonatal seizures and electro-physiology

Lunch12.30-13.00



New Gene Discoveries in

Neurogenetics

StrokeA population based

perspective on childhood stroke

Muscle & NerveDebate: Should we perform neonatal

screening for Duchenne muscular

dystrophy?


Afternoon Tea 14.00-14.15


StrokeTreatment

of childhood cerebrovascular

disease


Update in attention deficit hyperactivity

disorder

Muscle & NerveMeet the experts

Neonatal Neurology

New insights into periventricular

leukomalacia and risks of cerebral palsy

Closing Ceremony16.15-17.00

67www.icnc2012.com


FRID

AY1s

t JU

ne

sCIe

ntI

FIC

PRo

GR

AM

Me

FRIDAY 1st JUne07:00 - 07:20 BReAKFAst FoR BReAKFAst sessIon AttenDees

07:20-08:20 BReAKFAst teACHInG sessIon 4 M3Chair: Honey Heussler (Australia)

Parasomnias and sleep disorders: a case and video approach Honey Heussler, Australia; Shelly Weiss, Canada

08:30-09:10 FRAnK FoRD MeMoRIAL AWARD LeCtURe Q1+2 IntroductionJo Wilmshurst, South Africa

Australasian contributions to child neurology Robert Ouvrier, Australia

09:15-10.00 PLenARY LeCtURe Q1+2 IntroductionShinichi Hirose, Japan

Update on congenital myopathies Ikuya Nonaka, Japan

10:00-10:30 MoRnInG teA exHIBItIon HALL

10.15-10.30 PosteR AnD PLAtFoRM AWARDs exHIBItIon HALL

10:30-12:30 DeVeLoPMent AnD CoGnItIon Q1+2 neurobiological basis of autism Chairs: Suad Al Yamani (Saudi Arabia) / Raili Riikonen (Finland)

Autism in tuberous sclerosis Paolo Curatolo, Italy

Autism in Fragile X Walter Kaufmann, USA

Serotonin systems in autism Diane Chugani, USA

Management of autistic spectrum disorders Virginia Wong, Hong Kong

10:30-12:30 stRoKe M3 subtypes of childhood stroke Chairs: Hideo Yamanouchi (Japan) / Finbar O’Callaghan (UK)

Cerebral venous thrombosis Mahendra Moharir, Canada

Neonatal stroke Linda de Vries, Netherlands

68 www.icnc2012.com


IDAY

1st

JUn

esC

Ien

tIFI

CPR

oG

RA

MM

e

Haemorrhagic stroke Warren Lo, USA

Spinal cord infarction Hugo Arroyo, Argentina

10:30-12:30 MUsCLe AnD neRVe M4 Update in peripheral neuropathy Chair: Robert Ouvrier (Australia)

Advances and clinical trials in Charcot-Marie-Tooth disease Jo Wilmshurst, South Africa

Peripheral nerve imaging studies Nancy Kuntz, USA

Chronic immune demyelinating polyneuropathy Marc Tardieu, France

Early onset infantile neuropathy Monique Ryan, Australia

10:30-12:30 neonAtAL neURoLoGY M1+2 neonatal seizures and electrophysiology Chairs: Shinichi Niijima (Japan) / Michael Hayman (Australia)

Clinical and EEG features of neonatal seizures Lakshmi Nagarajan, Australia

A diagnostic approach to neonatal seizures Annie Bye, Australia

Epileptic encephalopathy and burst suppression EEG in the neonatal period Hitoshi Yamamoto, Japan

Amplitude integrated EEG in the neonatal unit Lena Hellstrom-Westas, Sweden

Neonatal EEG: future directions and opportunities Geraldine Boylan, Ireland

12:30-13:00 LUnCH exHIBItIon HALL

13:00-14:00 neW Gene DIsCoVeRIes In neURoGenetICs Q1+2 Chairs: Shinichi Hirose (Japan) / Matsuhiro Kato (Japan)

PRRT2: A newly identified gene for benign familial infantile epilepsy and infantile convulsions and choreoathetosis syndromeSarah Heron, Australia

ATP1A3 de novo mutations in alternating hemiplegia of childhood Mohamad Mikati, USA

69www.icnc2012.com


FRID

AY1s

t JU

ne

sCIe

ntI

FIC

PRo

GR

AM

Me

GLRB is the 3rd major gene-of-effect in hyperekplexia Mark Rees, UK

Mutations in the RNA exosome core component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration Michael Salman, Canada

13:00-14:00 stRoKe M3 A population based perspective on childhood strokeChairs: Tanyard Desudchit (Thailand) / Fenella Kirkham (UK)

Epidemiology, population based perspectives Gabrielle de Veber, Canada

Outcome of childhood stroke Finbar O’Callaghan, UK

13:00-14:00 MUsCLe AnD neRVe M4 Debate: should we perform neonatal screening for Duchenne muscular dystrophy?Chairs: Rakesh Patel (New Zealand) / Kathryn North (Australia)

Yes, we should perform population screening for Duchenne muscular dystrophyNigel Laing, Australia

No, we should not perform neonatal screening for Duchenne muscular dystrophyMonique Ryan, Australia

13:00-14:00 CHALLenGes In CHILD neURoLoGY 4 M1+2Chairs: Kazuie Iinuma (Japan) / Simon Williams (Australia)

Transition from paediatric care: building bridges to adult neurology Jennifer Boyd, Canada

Neuropathology in the genetic era: does neuropathology have a diagnostic role in child neurology? Sergio Rosemberg, Brazil

14:00-14:15 AFteRnoon teA exHIBItIon HALL

14:15-15:45 stRoKe Q1+2 treatment of childhood cerebrovascular diseaseChairs: Liping Zou (China) / Vijeya Ganesan (UK)

Acute therapies Fenella Kirkham, UK

Moyamoya: the role of surgical intervention Seung-Ki Kim, Korea

70 www.icnc2012.com


IDAY

1st

JUn

esC

Ien

tIFI

CPR

oG

RA

MM

e

Thrombolysis and endovascular treatments: an adult neurology experience Ferdi Miteff, Australia

14:15-16:15 DeVeLoPMent AnD CoGnItIon M3 Update in attention deficit hyperactivity disorderChairs: Yoichi Sakakihara (Japan) / Andre Venter (South Africa)

Update in ADHD genetics and clinical correlates Mark Bellgrove, Australia

ADHD comorbidities and developmental trajectories Daryl Efron, Australia

ADHD in the context of epilepsy Lieven Lagae, Belgium

Update on the medical management of ADHD Andre Venter, South Africa

14:15-16:15 MUsCLe AnD neRVe M4 Meet the experts Chairs: Nigel Laing (Australia)

Instructive neuropathy case studies Robert Ouvrier, Australia; Jo Wilmshurst, South Africa

Instructive muscle case studies Kathryn North, Australia; Nigel Clarke, Australia

14:15-16:15 neonAtAL neURoLoGY M1+2 new insights into periventricular leukomalacia and risks of cerebral palsyChairs: Akira Oka (Japan) / Michael Shevell (Canada)

Challenging traditional concepts in the aetiology of CP: prematurity and maternal factors Eli Lahat, Israel

Timing of perinatal brain injury Shinichi Niijima, Japan

Neonatal EEG in determining risk to the preterm brain Akihisa Okumura, Japan

The effect of hypoxia/ischaemia and inflammation on white matter injury in the immature brain Chao-Ching Huang, Taiwan

71www.icnc2012.com


FRID

AY1s

t JU

ne

sCIe

ntI

FIC

PRo

GR

AM

Me

16:15-17:00 CLosInG CeReMonY Q1+2 Address from the Secretary of AOCNAHitoshi Yamamoto, Japan

Address from the President of ICNAHarry Chugani, USA

Address from the Chair of ICNC 2014Sergio Rosemberg, Brasil

Address from the Chair of AOCCN 2013Suad Al Yamani, Saudi Arabia

Congress highlights and closing comments from the CEO of ANZCNSRichard Webster, Australia

72 www.icnc2012.com

Joint 12th ICNC and 11th AOCCNPR

oG

RA

MM

eIn

FoRM

AtIo

n

sCIentIFIC PRoGRAMMe InFoRMAtIon

Mon 28th Tue 29th Wed 30th Thu 31st Fri 1st

Poster display 10.00-16.30 10.00-16.30 10.00-16.30 10.00-16.30 -

Poster tours 12.40-13.25 12.40-13.25 12.40-13.25 12.40-13.25 -

Speed Date a Speaker 12.45-13.15 12.45-13.15 12.45-13.15 12.45-13.15 12.30-13.00

Meet a Mentor 16.10-16.30 16.10-16.30 16.10-16.30 16.10-16.30 -

Posters

Posters are exhibited in the Exhibition Hall on the Foyer Level of the BCEC.

Poster presenters are asked to stand by their posters from 12.30 – 13.30 on their allocated day. They must set up their posters before 10.00 on the day of their poster presentation and remove the poster by 17.00 on the same day. Posters not removed by close of the congress day will be disposed of by the Congress Secretariat.

social networking opportunities

Several important opportunities have been provided to delegates attending ICNC/AOCCN 2012 to have an enhanced social and networking experience, including Poster Tours, Speed Date a Speaker and Meet a Mentor. Advance bookings are required for Speed Date a Speaker and Meet a Mentor.

Platform/Poster Abstracts

Abstracts for platforms and posters can be found in the ICNC/AOCCN 2012 e-supplement in Developmental Medicine and Child Neurology:

http://onlinelibrary.wiley.com/doi/10.1111/dmcn.2012.54.issue-s4/issuetoc

Printed versions of the Developmental Medicine and Child Neurology supplement will only be available to the first 50 full congress delegates who visit the Australia and New Zealand Child Neurology Society table in the Exhibition Hall on Monday to Thursday from10.00-10.30 only.

ICNC/AOCCN 2012 delegates also have complimentary electronic access to the proceedings of the Australasian Academy of Cerebral Palsy and Developmental Medicine congress, which is being held alongside ICNC/AOCCN 2012 at the BCEC:

http://onlinelibrary.wiley.com/doi/10.1111/dmcn.2012.54.issue-s5/issuetoc

© B

risba

ne M

arke

ting

73www.icnc2012.com


PRo

GR

AM

Me

InFo

RMAt

Ion

Poster tours

Poster tours will leave from the signposted departure table in the Exhibition Hall.

Tour start times: 12:40 (20 minutes) 13:05 (20 minutes)

DAY POSTER SESSION TOUR LEADERS Times

Monday 28th May Epilepsy Annie Bye (Koala)Lakshmi Nagarajan (Tassie Devil)

12:40 / 13:0512:40 / 13:05

Monday 28th May CNS infection Charles Newton (Tassie Tiger)Rob Rust (Quoll)

12:40 / 13:0512:40 / 13:05

Monday 28th May Metabolic Yasutoshi Koga (Wombat)David Thorburn (Shark)Wang-Tso Lee (Kookaburra)

12:4012:40 / 13:0513:05

Monday 28th May Movement Disorders Paddy Grattan-Smith (Emu) 12:40 / 13:05

Tuesday 29th May Epilepsy John Lawson (Koala)Helen Cross (Tassie Devil)Hitoshi Yamamoto (Quoll)

12:40 / 13:0512:40 / 13:0512:40

Tuesday 29th May Development, Cognition and Psychiatry 1

Cynthia Sharpe (Kangaroo)Kevin Collins (Quoll)

12:40 / 13:0513:05

Tuesday 29th May Neurocutaneous and Neurogenetic Disorders

Rick Leventer (Wombat)Sarah Heron (Tassie Tiger)

12:40 / 13:0512:40

Tuesday 29th May Headache, Neurosurgery and Neuroimaging

Kenneth Mack (Shark)Ian Wilkinson (Emu)Barry Appleton (Kookaburra)Steve Ashwal (Emu)

12:40 / 13:0512:4013:0513:05

Wednesday 30th May Cerebral Palsy and Rehabilitation

Richard Webster (Tassie Devil)Kate Sinclair (Kangaroo)

12:40 / 13:0512:40

Wednesday 30th May Epilepsy Steve Malone (Koala)Mohamad Mikati (Tassie Tiger)

12:40 / 13:0512:40 / 13:05

Wednesday 30th May Neuroimmunology Hiroshi Sakuma (Wombat)Andrew Kornberg (Shark)

12:40 / 13:0512:40 / 13:05

Wednesday 30th May Development, Cognition and Psychiatry 2

Kevin Collins (Emu) 12:40 / 13:05

Thursday 31st May Epilepsy Claire Pridmore (Koala)Ingrid Scheffer (Tassie Devil)

12:40 / 13:0512:40

Thursday 31st May Neurocritical Care & Stroke

Fenella Kirkham (Wombat)Mark Mackay (Tassie Devil)

12:40 / 13:0513:05

Thursday 31st May Muscle and Nerve Michael Fahey (Quoll)Haluk Topaloglu (Tassie Tiger)John Bodensteiner (Tassie Tiger)

12:4012:4013:05

Thursday 31st May Fetal and Neonatal Neurology

Geraldine Boylan (Emu)Cynthia Sharpe (Kangaroo)

12:40 / 13:0513:05

74 www.icnc2012.com


on

DAY

28tH

MAY

Post

eR s

essI

on

s PosteR sessIonsMonDAY 28tH MAY12:30-13:30 Poster session: epilepsy exhibition Hall

A1-0001 Hypoglycemia–occipital syndrome: A specific neurologic syndrome following neonatal hypoglycemia Parvaneh Karimzadeh, Iran

A1-0002 Mozart K. 545 is as effective as Mozart K. 448 in reducing epileptiform discharges in children with epilepsy: the role of harmonics Lung-Chang Lin, Taiwan

A1-0003 epilepsy in children with trisomy 18 Tomohiro Kumada, Japan

A1-0004 Parental fear of the first febrile seizure in their childHideaki Kanemura, Japan

A1-0005 WItHDRAWnNeziha Gouider-Khouja, Tunisia

A1-0006 WItHDRAWnNeziha Gouider-Khouja, Tunisia

A1-0007 Rufinamide efficacy and safety as adjunctive treatment in children with refractory focal epilepsy: the first Italian prospective studyRomina Moavera, Italy

A1-0007a Ketogenic diet in early myoclonic encephalopathy due to non-ketotic hyperglycinemiaRomina Moavera, Italy

A1-0008 Antiepileptic treatment before seizure onset reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complexSergiusz Jozwiak, Poland

A1-0009 Mosaic duplication of FoxG1 may cause West syndromeJun Tohyama, Japan

A1-0010 PLAtFoRM PResentAtIon Progressive gait deterioration in adolescents with Dravet syndromeJill Rodda, Australia (See Wednesday Epilepsy Platform B3-P5)

A1-0011 efficacy of continuous high dose midazolam infusion in childhood refractory generalized convulsive status epilepticusAfshin Fayyazi, Iran

A1-0012 Antiepileptic drugs utilization in children in Hong KongKaren Kwong, China

A1-0013 Incidence of kidney stones with topiramate treatment in paediatric patientsAdel Mahmoud, Saudi Arabia

A1-0014 Characteristics of seizures associated with rickets in breastfed infantsYoung Se Kwon, Korea

A1-0015 optical flow information and video seizure recognitionBappaditya Mandal, Singapore

A1-0016 neuropsychiatric impairment in benign childhood epilepsy with centro-temporal spikesTae-Sung Ko, Korea

A1-0017 Utility of ambulatory eeG in a paediatric populationChoong Yi Fong, Australia

A1-0018 Clinical and eeG analyses of four patients with CDKL5 mutationsMustuki Shioda, Japan

A1-0019 exercise therapy in children with benign rolandic epilepsyHeung Dong Kim, Korea

75www.icnc2012.com


Mo

nD

AY28

tH M

AYPo

steR

ses

sIo

ns

A1-0020 Chronic reduction in cerebellar activity of amygdala kindled ratsJohan Vles, The Netherlands

A1-0021 Focal and generalized epilepsies in well-functioning children – situation after 10 yearsOrvar Eeg-Olofsson, Sweden

A1-0022 summer camp for children and teens with epilepsy - our experienceLjerka Cvitanovic-Sojat, Croatia

A1-0023 Low-dose, once-a-day topiramate administration in newly diagnosed benign childhood epilepsy with centrotemporal spikesYoung-Jong Woo, Korea

A1-0024 epilepsy in two long term survival cases with trisomy 13Tomoko Matsubayashi, Japan

12:30-13:30 Poster session: Cns Infection exhibition Hall

B1-0001 A recurrent case of acute encephalopathy with biphasic seizures and late reduced diffusion after acute necrotizing encephalopathyChihiro Yonee, Japan

B1-0002 serum and CsF s100B, neuron specific enolase, and tau protein in acute encephalopathy with biphasic seizures and late reduced diffusionTakashi Shiihara, Japan

B1-0003 the clinical characteristics and diagnosis of mycoplasma pneumoniae infection central nervous system sequelaeChih-fen Hu, Taiwan

B1-0004 A case of MRI negative neurobrucellosis with isolated spinal cord involvementZuhal Yapici, Turkey

B1-0005 Group A coxsackie virus-associated encephalitis/encephalopathy: a retrospective hospital-based study in JapanKoichi Aizaki, Japan

B1-0006 A case of acute cerebellitis with persistent hypometabolism in cerebellum assessed by [F-18] FDG-Pet imagingHideki Shimomura, Japan

B1-0007 the value of fluorescent microscopy and PCR in the early diagnosis of tuberculous meningitis and mycobacterial resistance: preliminary observationsRegan Solomons, South Africa

B1-0008 neurological manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a report of four childrenJohannes Schoeman, South Africa

B1-0009 Value of different staging systems for predicting neurological outcome in childhood tuberculous meningitisRonald Van Toorn, South Africa

B1-0010 A review of childhood spinal tuberculosis in Durban, KwaZulu natal, south AfricaVasantha Govender, South Africa

B1-0011 Human herpesvirus-6 (HHV-6) encephalitis leading to brain death after prolonged status epilepticusSung-Min Cho, Korea

B1-0012 Paediatric early-onset human herpes virus-6 encephalitis after umbilical cord blood transplantationShoko Matsushita, Japan

76 www.icnc2012.com


on

DAY

28tH

MAY

Post

eR s

essI

on

s

B1-0013 Cytokines and chemokines in cerebrospinal fluid in children with facial nerve palsy caused by borrelia in the Czech RepublicVladimír Komárek, Czech Republic

B1-0014 neurological complications of bacterial meningitis in southern nigerian childrenAngela Frank-Briggs, Nigeria

B1-0015 Clinical features and prognostic factors of neurologic outcome in group B streptococcus meningitisEunyoung Kim, Democratic People’s Republic of Korea

B1-0016 neurologic manifestations of enterovirus 71 infection in children in Ulsan and Busan, Korea, 2010Kyung Yeon Lee, Korea

B1-0017 An unusual case of pure parasympathetic autonomic neuropathy due to enterovirus infectionFurene Wang, Singapore

B1-0018 neurologic outcome after extracorporeal cardiopulmonary resuscitation in children with enterovirus 71 infection-related cardiopulmonary failureTung-Ming Chang, Taiwan

B1-0019 enteroviral meningitis in younger infants with high feverSoo Ahn Chae, Korea

B1-0020 Parechoviruses: a common cause of infant sepsis and seizuresThorsten Stanley, New Zealand

B1-0021 Clinical profiles and magnetic resonance imaging in children with encephalitisYu-Ching Chang, Taiwan

B1-0022 Paediatric febrile encephalopathy and encephalitis - experience in Brisbane, AustraliaRon Loh, UK

B1-0023 Detection of Cns involvement in congenital cytomegalovirus infection identified in neonatal screening: clinical usefulness of ultrasonographyHiroyuki Iwasaki, Japan

B1-0024 scrub typhus and neuropsychological outcome: a case studyCatherine Cox, Singapore

B1-0025 opsoclonus-myoclonus syndrome in a 14-year old girl with dengue encephalitis: a case reportLoudella Calotes-Castillo, Philippines

B1-0026 two cases of granulomatous amoebic meningoencephalitis caused by balamuthia mandrillarisShekeeb Mohammad, Australia

B1-0027 WItHDRAWnLi Jiang, China

B1-0028 severe neurobrucellosis in early infancyAkin Iscan, Turkey

B1-0029 Proliferation and differentiation of endogenous neural stem cells during experimental streptococcus pneumoniae meningitisLing Li, China

12:30-13:30 Poster session: Metabolic exhibition Hall

C1-0001 neurological phenotypes in niemann-Pick type C disease: unraveling an overlooked neurometabolic disorderCharles Lourenco, Brasil

C1-0002 neurological findings in mucopolysacharidosis type II (Hunter syndrome)Charles Lourenco, Brasil

77www.icnc2012.com


Mo

nD

AY28

tH M

AYPo

steR

ses

sIo

ns

C1-0003 When all the joy is gone: the psychological burden of Fabry Disease in childhoodCharles Lourenco, Brasil

C1-0004 MoVeD to A1-0007a

C1-0005 the effect of the ketogenic diet in critically ill children with pyruvate dehydrogenase complex dysfunction and encephalopathyKatarzyna Kotulska, Poland

C1-0006 MeLAs A3243G mutation is the commonest cause of mitochondrial sensorineural hearing loss in singapore childrenStacey Tay, Singapore

C1-0007 Diagnostic accuracy of blood and CsF lactate in identifying children with mitochondrial diseases affecting the central nervous systemKeitaro Yamada, Japan

C1-0008 Pan-PPAR agonist does not induce mitochondrial biogenesis, but delays disease progression in a late-onset mitochondrial myopathy mouseShuichi Yatsuga, Finland

C1-0009 oxidative stress markers and phosphorus magnetic resonance spectroscopy in a patient with GLUt1 deficiency treated with the modified Atkins dietYuri Kitamura, Japan

C1-0010 the spectrum of clinical, MRI & eeG findings in Menkes syndrome: report on six patients from south IndiaParayil Bindu, India

C1-0011 An infant with methylmalonic aciduria caused by vitamin B12 deficiencyKonomi Shimoda, Japan

C1-0012 Paediatric neurotransmitter disease: experiences of a regional hospitalEric Yau, Hong Kong

C1-0013 outcome of primary mitochondrial disease in childrenEric Yau, Hong Kong

C1-0014 spectrum of mitochondrial diseases in a tertiary referral centre in Hong KongCheuk-Wing Fung, Hong Kong

C1-0015 normal diurnal fluctuations of CsF glucose, CsF/blood glucose ratio and CsF lactateMichèl Willemsen, The Netherlands

C1-0016 Phosphoglycerate kinase deficiencyGrahame Wise, Australia

C1-0017 A case of creatine deficiency with seizureFereshteh Saeed Tehrani, Iran

C1-0018 Distinct neuroimaging features of fucosidosisPuneet Jain, India

C1-0019 scurvy in a 5 year old in the developed worldTyson Ware, Australia

C1-0020 spectrum of lysosomal storage disorders in omanAmna Futaisi, Oman

C1-0021 novel mitochondrial complex II deficiency presenting with renal failure, corneal dystrophy, myopathy and transient pancytopenia with pancreatic insufficiencyMaina Kava, Australia

C1-0022 First report of glucose transporter-1 deficiency syndrome in a Korean with a novel splice site mutationSung Koo Kim, Korea

C1-0023 the anion gap is a simple and useful test for diagnosing mitochondrial cytopathies, experience in a paediatric series in Mexico CityVioleta Medina-Crespo, Mexico

C1-0024 WItHDRAWnMuhammad Mahajnah, Israel

78 www.icnc2012.com


on

DAY

28tH

MAY

Post

eR s

essI

on

s

C1-0025 Lesch nyhan disease extending into adulthoodTomohiro Nakayama, USA

C1-0026 A south Indian family with two children with intractable seizures: biochemical, molecular and prenatal diagnosis of pyridoxine-dependant epilepsyVelayutham Murugan, India

C1-0027 An Indian experience of atlanto-axial stabilization for upper cervical anomalies in Morquio syndromeVelayutham Murugan, India

C1-0028 two Indian siblings with PLP1 duplication-positive Pelizaeus-Merzbacher diseaseVelayutham Murugan, India

C1-0029 Clinical features of mitochondrial DnA m.3243A>G mutation in 47 Chinese familiesYinan Ma, China

12:30-13:30 Poster session: Movement Disorder exhibition Hall

D1-0001 Long-term aripiprazole treatment of refractory tourette disorderHuei-Shyong Wang, Taiwan

D1-0002 Clinical and genetic investigation of 14 Japanese patients with hyperekplexiaJun Mine, Japan

D1-0003 Hyperekplexia: a case report confirmed by genetic testingSharon Cherk, HKSAR

D1-0004 Acute immune-mediated ataxia in adolescenceRobert Stowe, USA

D1-0005 Drug induced extrapyramidal syndrome at a paediatric emergency departmentMing-Yu Chang, Taiwan

D1-0006 Choreo-dystonic movements and cardiac fibro-elastoma in a child: a non-fortuitous association?Bernard Echenne, France

D1-0007 the pathophysiological study of paroxysmal kinesigenic dyskinesia using movement-related cortical potentials and contingent negative variationsMasaya Kubota, Japan

D1-0008 Globus pallidus deep brain stimulation provides benefit and allows medication reduction in young childrenJonathan Mink, USA

D1-0009 Benign hereditary chorea: report of three cases illustrating the contribution of array CGH for molecular diagnosisBernard Echenne, France

D1-0010 Clinical clues to differentiating genetic versus non-genetic aetiologies of childhood ataxiasMichael Shevell, Canada

D1-0011 Movement Disorder Childhood Rating scale as an outcome measure in the treatment of developmental movement disordersGiovanni Cioni, Italy

D1-0012 enhancing learners’ visual search in video casesThomas Balslev, Denmark

D1-0013 Kinematics of tremor in childrenJonathan Mink, USA

79www.icnc2012.com


tUes

DAY

29tH

MAY

Post

eR s

essI

on

stUesDAY 29tH MAY12:30-13:30 Poster session: epilepsy exhibition Hall

A2-0001 Growth of children on a ketogenic diet: does the protein to energy ratio matter?Mark Mackay, Australia

A2-0002 the impact of antihistamine administration on the clinical characteristics of febrile seizuresYuko Sakaue, Japan

A2-0003 Complex visual and auditory hallucinations in prepubertal children: review of eleven casesGillian Riordan, South Africa

A2-0004 Usefulness of methylphenidate for attention deficit hyperactivity disorder in patients with epilepsyYoshiko Hirano, Japan

A2-0005 early postictal electroencephalography and correlation with clinical findings in children with febrile seizuresEun Hye Lee, Korea

A2-0006 Practical difficulties in implementing ketogenic diet in Hong Kong Chinese patients – experience in a tertiary hospitalEva Fung, Hong Kong

A2-0007 Brain-derived neurotrophic factor expression after seizures in mice treated with the ketogenic dietDong Wook Kim, Korea

A2-0008 electrographic features during acute episodes of vomiting in cyclical vomiting syndromeJeremy Lin, Singapore

A2-0009 Post-surgical outcome in patients with epileptic spasmsYukiko Mogami, Japan

A2-0010 the efficacy for partial tonic seizures and sedative side effects of newer antiepileptic drugs can be predicted from their mechanism of actionKenji Sugai, Japan

A2-0011 Hippocampal hyperintensity on diffusion-weighted images is specific to prolonged febrile seizuresHiroyuki Yamamoto, Japan

A2-0012 Correlation between epilepsy and attention deficit hyperactivity disorder: a nationwide population base case-control studyZheng-Nan Chin, Taiwan

A2-0013 Predictive factors for infantile spasms in infants with periventricular leukomalaciaNami Soga, Japan

A2-0014 Usefulness of multimodal imaging for pre-surgical localization in non-lesional paediatric epilepsy patientsJoonwon Kang, Korea

A2-0015 oxcarbazepine induced absence seizures in childrenJao-Shwann Liang, Taiwan

A2-0016 Profile of West syndrome in a tertiary centre in north India: 213 casesSheffali Gulati/Puneet Jain, India

A2-0016a neurodevelopmental and epilepsy outcome in children aged one to five years with infantile spasm: a cross-sectional studyPuneet Jain, India

A2-0017 WItHDRAWnAbdul Wahab, Germany

80 www.icnc2012.com


esD

AY29

tH M

AYPo

steR

ses

sIo

ns

A2-0018 Is neonatal onset epilepsy an independent risk factor for mortality in children with epilepsy? A 30 year population-based studyKatherine Nickels, USA

A2-0019 seizures during acute lymphoblastic leukemia treatment in childrenIn Goo Lee, Korea

A2-0020 Leg spasms: reflex simple partial seizures or cortical reflex myoclonus?Manish Prasad, UK

A2-0021 Clinical characteristics of children suffering from Dravet syndrome with de novo sCn1A mutationEric Yau, Hong Kong

A2-0022 seizure outcome in children with epilepsy after resective brain surgerySnehal Shah, Australia

A2-0023 the poor outcome of epilepsy in children with acute febrile encephalopathyYoung-Jong Woo, Korea

A2-0024 steroid dependent early epileptic encephalopathy: think glucose transporter type 1 deficiency syndromeVenkateswaran Ramesh, UK

A2-0025 Is it necessary to perform an eeG before the treatment of attention deficit hyperactivity disorder?Banu Anlar, Turkey

12:30-13:30 Poster session: Development, Cognition and Psychiatry 1 exhibition Hall

B2-0001 Characteristics of the neurological manifestations of paediatric perisylvian polymicrogyriaTomoyuki Takano, Japan

B2-0002 Microarray as the first genetic test in global developmental delayMichael Shevell, Canada

B2-0003 Developmental changes in frontal lobe function during verbal fluency task: a multi-channel near-infrared spectroscopy activation studyTomoko Tando, Japan

B2-0004 electroencephalographic findings of autistic spectrum disordersMariko Maezawa, Japan

B2-0005 Long-term administration of intranasal oxytocin to early adolescents with autistic spectrum disorderMasaya Tachibana, Japan

B2-0006 Pilot study for subgroup classification for autism spectrum disorder based on dysmorphology and physical measurements in Chinese childrenVirginia Wong, Hong Kong

B2-0007 Autistic spectrum disorder and mitochondrial dysfunctionTomohiro Nakayama, USA

B2-0008 ethnicity and attention deficit hyperactivity disorder prevalence in AsiaYoichi Sakakihara, Japan

B2-0009 event-related potential differences between normal and attention deficit/hyperactivity disorder children in processing pure tones and lexical tonesMing-Tao Yang, Taiwan

B2-0010 Relationship of attention-deficit hyperactivity disorder and sleep disorders: an event-related potential study using the Posner paradigmPou-Leng Cheong, Taiwan

81www.icnc2012.com


tUes

DAY

29tH

MAY

Post

eR s

essI

on

s

B2-0011 Cortisol awakening response improves after a summer treatment program for children with ADHDYushiro Yamashita, Japan

B2-0012 Association between allergic diseases and attention-deficit hyperactivity disorder in childhood: a population-based studyJeng-Dau Tsai, Taiwan

B2-0013 Follow-up study on health examinations for developmental disorders in five-year-old childrenYuji Inaba, Japan

B2-0014 sleep behaviors comparing very low birthweight infants and extremely low birth weight infants at one year oldYoko Asaka, Japan

B2-0015 Prognostic factors for developmental delay in preterm infantsKeonsu Lee, Korea

B2-0016 the impact of transient perinatal hypocalcemia on brain-derived neurotrophic factor expression in the hippocampus of developing ratsGeng-Chang Yeh, Taiwan

B2-0017 Maternal stress reduces parvalbumin positive GABAergic interneuron proliferationTaku Uchida, Japan

B2-0018 Plasma IGF-1, serum ghrelin, and the head growth in patients with Rett syndromeMunetsugu Hara, Japan

B2-0019 Pilot study on improving the social skills of Japanese children with high-functioning pervasive developmental disorders: development of the Dokkyo-nAKAMA programNoriko Kato, Japan

B2-0020 the incidence of intellectual impairment in children in east Moselle, FranceValentina Kieffer, France

B2-0021 Changes in salivary cortisol levels as a prognostic predictor in children with anorexia nervosaIkuhiko Shibuya, Japan

B2-0022 A case of tetrasomy 18p with tracheomalaciaAyako Goto, Japan

12:30-13:30 Poster session: neurocutaneous and neurogenetic Disorders exhibition Hall

C2-0001 survival with Rett syndrome: comparing Rett’s original sample with data from the Australian Rett syndrome DatabaseHelen Leonard, Australia

C2-0002 efficacy and safety of everolimus treatment for subependymal giant cell astrocytoma in children under 3 years with tuberous sclerosis complexKatarzyna Kotulska, Poland

C2-0003 Description of an African cohort of children with tuberous sclerosis complexPauline Samia, South Africa

C2-0004 Parental understanding of tuberous sclerosis complex: impact of written information in an African settingPauline Samia, South Africa

C2-0005 epidemiology of tuberous sclerosis complex: a study of new diagnoses in children 2004-2009John Lawson, Australia

82 www.icnc2012.com


esD

AY29

tH M

AYPo

steR

ses

sIo

ns

C2-0005a Cognition and autism in preschool age children with tuberous sclerosis complexJohn Lawson, Australia

C2-0006 tuberous sclerosis and polycystic kidney disease: potential role of mtoR inhibitors?Terrence Thomas, Singapore

C2-0007 the relationship between neuroimaging findings and neuropsychiatric comorbidities in children with tuberous sclerosis complexWang-Tso Lee, Taiwan

C2-0008 Attention deficit hyperactivity disorder and binge eating disorder in a patient with 2q21.1-q22.2 deletionPaolo Curatolo, Italy

C2-0009 the epidemiology of chronic ataxia in children in Manitoba, CanadaMichael Salman, Canada

C2-0010 Acute renal failure due to neurogenic bladder in twin patients with late-onset Cockayne syndromeAkiko Koyama, Japan

C2-0011 Genetic white matter disorders: investigating leukodystrophies/leukoencephalopathies in childrenCharles Lourenco, Brasil

C2-0012 A case of neonatal sturge-Weber syndrome presenting with cortical calcification at birthSeiichiro Yoshioka, Japan

C2-0013 sporadic paraspinal plexiform neurofibromas in two paediatric patients without neurofibromatosis type 1Vinay Puri, USA

C2-0014 neurofibromatosis type 2 in childhood: major complications and treatment modalitiesSimone Ardern-Holmes, Australia

C2-0015 Characterisation of gallium-octreotide Pet findings in patients with tumours associated with neurofibromatosis type 2Simone Ardern-Holmes, Australia

C2-0016 transcranial doppler investigation of clinical and subclinical cerebral vasculopathy in paediatric neurofibromatosis type 1Thomas Geller, USA

C2-0017 en coup de sabre and new-onset seizure in infancyChalongchai Phitsanuwong, USA

C2-0018 Autosomal recessive facial nerve paresis and ocular colobomasMajed Dasouki, USA

C2-0019 Cognitive and speech-language performance in children with ataxia telangiectasiaMichèl Willemsen, The Netherlands

C2-0020 sjögren-Larsson syndrome – an updateMichèl Willemsen, The Netherlands

C2-0021 Clinical characteristics and molecular genetic analysis of the PLP1 gene in 19 unrelated patients with Pelizaeus-Merzbacher diseaseJon Soo Kim, Korea

C2-0022 Pelizaeus-Merzbacher disease phenotype in a female infant carrier of a duplication of xq21.3q23Gyula Acsadi, USA

C2-0023 Clinical and genetic study of eighteen Chinese patients with Alexander diseaseYe Wu, China

83www.icnc2012.com


tUes

DAY

29tH

MAY

Post

eR s

essI

on

s

C2-0024 Mutation and copy number variation analysis of the AtP7A gene in patients with Menkes diseaseJing-min Wang, China

C2-0025 Facial dysmorphism, hirsutism and failure to thrive as a manifestation of Leigh disease in children with sURF1 mutationsSubramanian Ganesan, UK

C2-0026 non-classical clinical manifestation of glucose transporter type 1 deficiency syndrome in three Chinese casesXinhua Bao, China

C2-0027 Amygdala functioning to psychic trauma and temperament in childrenHideyuki Hidaka, Japan

C2-0028 WItHDRAWnNeziha Gouider-Khouja, Tunisia

C2-0029 Joubert syndrome with ocular defect in a tunisian babyNouha Bouayed Abdelmoula, Tunisia

C2-0030 PoMt enzyme activity in Walker-Warburg syndromeMaina Kava, Canada

12:30-13:30 Poster session: Headache, neurosurgery and neuroimaging exhibition Hall

D2-0001 Primary stabbing “ice pick” headacheMohammed Jan, Saudi Arabia

D2-0002 Ruptured giant middle cerebral artery aneurysm in infancyMohammed Jan, Saudi Arabia

D2-0003 A case of pseudotumor cerebri manifesting as unilateral abducens nerve palsy and stiff neckYoung Chang Kim, Korea

D2-0004 Migraine-triggered seizuresGabriel Martino, Argentina

D2-0005 Atypical forms of migraine in childhood, our experience (1994-2010)Gabriel Martino, Argentina

D2-0006 A case of newly diagnosed type 2 diabetes mellitus with daily headachesYoung-Il Rho, Korea

D2-0007 Body mass index and headache in school childrenYoung-Il Rho, Korea

D2-0008 Dietetic management effectiveness in children with headachesMarisela Garcia, USA

D2-0009 Visual field measurement in young children with neurological disorders using a new eye tracking techniqueIan Murray, UK

D2-0010 Age-dependent differences in trigemino-vascular responsiveness of a migraine modelPi-Chuan Fan, Taiwan

D2-0011 Paediatric migraine in an economically deprived populationDirce Fujiwara, Brasil

D2-0012 Alterations of the cerebral venous circulation in children and adolescents with migraine and tension-type headachesYury Nesterovskiy, Russia

D2-0013 Dynamics of age and gender-dependent correlates of recurrent headache in Bangladeshi scholarsNarayan Chandra Saha, Bangladesh

D2-0014 Impact of recurrent headache on school performance, sleep pattern and socio-economic norms among Bangladeshi school childrenNarayan Chandra Saha, Bangladesh

84 www.icnc2012.com


esD

AY29

tH M

AYPo

steR

ses

sIo

ns

D2-0015 Brain MRI and eeG in school-aged children with migraineSmail Zubcevic, Bosnia and Herzegovina

D2-0016 spectrum of neurological problems in a cohort of paediatric nephrology patients and their short-term outcomeLokesh Lingappa, India

D2-0017 Paediatric migraine - a new definitionMV Francis, India

D2-0018 earliest migraine manifestations in lifeMV Francis, India

D2-0019 Cerebrospinal fluid flow quantification across the cerebral aqueduct in children and adults with two-dimensional cine phase-contrast cine MR imagingHueng-Chuen Fan, Taiwan

D2-0020 A profile of congenital brain malformation in Durban, south AfricaRajeshree Govender, South Africa

D2-0021 Diffusion tensor imaging of language pathway abnormalities in children with developmental dysphasiaVladimír Komárek, Czech Republic

D2-0022 Isolated bilateral symmetrical dentate nucleus signal changes in a toddler with PPt-1 related neuronal ceroid lipofuscinosis type I: a new MRI findingMahesh Kamate, India

D2-0023 Frontal cerebral convexity lipoma with associated polymicrogyria – imaging and eeG featuresAlexandra Johnson, Australia

D2-0024 Attention-deficit hyperactivity disorder in childhood and adolescence is associated with increased gray matter volume in the insulaAkemi Tomoda, Japan

D2-0025 serial brain MR imaging in patients undergoing liver transplantation for congenital absence of the portal veinHiroshi Terashima, Japan

D2-0026 Hippocampal MRI volumetry among children attending special educationSuvi Koskinen, Finland

D2-0027 effects of chemotherapy on the brain in childhood: diffusion tensor imaging of subtle white matter damageShigemi Morioka, Japan

D2-0028 spectrum of imaging appearances in Australian children with central nervous system haemophagocytic lymphohistiocytosisMichael Guandalini, Australia

D2-0029 Brain MRI findings correlate with neurodevelopmental outcome at 5 years, in children with univentricular hearts, including hypoplastic left heart syndromeAnne Sarajuuri, Finland

D2-0030 neuroplasticity of the brain as demonstrated by young dancersWei-Yuan Huang, Taiwan

D2-0031 Magnetic resonance imaging observations in disorders of intermediary metabolism in children: study of 50 patients from a tertiary care hospitalParayil Bindu, India

D2-0032 Corticospinal tract integrity and motor outcomes using diffusion tensor imaging in perinatal strokeJacquie Hodge, Canada

85www.icnc2012.com


tUes

DAY

29tH

MAY

Post

eR s

essI

on

s

D2-0033 Impact of corticosteroid therapy on cerebral vessel imaging in children with primary Cns vasculitisSusanne Benseler, Canada

D2-0034 Migraine in the paediatric age group: a diagnostic challengeHanan El Shakankiry, Saudi Arabia

D2-0035 Acute and long term effectiveness of intravenous dihydroergotamine in the treatment of chronic daily headaches in the paediatric populationRobert Rust, USA

D2-0036 Headache risk factors in children and adolescence in Chungbuk, KoreaWon Seop Kim, Korea

D2-0037 Differential diagnostic features of liquor dynamic cephalgia in adolescentsShamansurov Shaanvar, Uzbekistan

D2-0038 Developmental venous anomalies in newborn babies diagnosed by cerebral ultrasoundChaw-Liang Chang, Taiwan

86 www.icnc2012.com


eDn

esD

AY30

tH M

AYPo

steR

ses

sIo

ns WeDnesDAY 30tH MAY

12:30-13:30 Poster session: Cerebral Palsy and Rehabilitation exhibition Hall

A3-0001 establishing child neurology services in Angra dos Reis, with populations distant from large urban centersInês Seppi, Brasil

A3-0002 Access to paediatric neurology care in underserved populations: a comparison of two staffing models in medical home settingsDavid Urion, USA

A3-0003 Kernicterus in children attending tygerberg Children Hospital: a retrospective case seriesPhilip Brink, South Africa

A3-0004 Characteristics of the sleep quality and autonomic nerve activity during sleep in severe physically handicapped children receiving medical careGakuyo Matsui, Japan

A3-0005 Does antenatal tobacco or alcohol exposure influence a child’s cerebral palsy? A population-based studyMichael Shevell, Canada

A3-0006 Potential contribution of interneurons to neuronal plasticity in the cerebral cortex of the human brain: an immunohistochemical studyMayumi Matsufuji, Japan

A3-0007 sociocultural issues and causes of cerebral palsy in Port Harcourt, nigeriaAngela Frank-Briggs, Nigeria

A3-0008 Clinical features of congenital bulbar palsyHiroshi Arai, Japan

A3-0009 Bulbar dysfunction after hypothermia for neonatal hypoxic-ischemic encephalopathyYukihiro Kitai, Japan

A3-0010 “tailor-made therapy” for spasticity in the disabledTetsuro Nagasawa, Japan

A3-0011 Psychosocial adjustment in Dutch children with cerebral palsy and comparison with healthy controls and boys with Duchenne muscular dystrophyJohan Vles, The Netherlands

A3-0012 Quality of life in children with cerebral palsy: a cross-sectional study in the south of the netherlandsJohan Vles, The Netherlands

A3-0013 Factors affecting the functional outcome in children with upper obstetrical brachial plexus (erbs) palsy: following intensive non-surgical rehabilitationSanjaya Fernando, Sri Lanka

A3-0014 Visualization of language and pyramidal tracts in young patients with severe cerebral palsy: a diffusion tensor imaging studyR Jeroen Vermeulen, The Netherlands

A3-0015 Change in the clinical spectrum of cerebral palsy over two decades in north India: an analysis of 1212 casesArushi Saini, India

A3-0016 Impact of social factors on medical and functional outcomes among school-age children with cerebral palsyMichael Msall, USA

A3-0017 WItHDRAWnXiangRong Zheng, China

A3-0018 Current status of intrathecal baclofen therapy for children with severe spasticity and/or dystoniaHirofumi Kashii, Japan

87www.icnc2012.com


WeD

nes

DAY

30tH

MAY

Post

eR s

essI

on

s

A3-0019 How to assess active and passive components of muscle resistance in children with cerebral palsyMaria Willerslev-Olsen, Denmark

12:30-13:30 Poster session: epilepsy exhibition Hall

B3-0001 sCn1A analysis in generalized epilepsy with febrile seizures plus and severe myoclonic epilepsy in infancyI-Ching Chou, Taiwan

B3-0002 Postnatal interleukin-1b enhances adulthood seizure susceptibility after prolonged experimental febrile seizure in infantile ratsMitsumasa Fukuda, Japan

B3-0003 Classification of childhood epilepsies and epileptic syndromes in a tertiary paediatric neurology clinic using a customized revised ILAe classificationTeik Beng Khoo, Malaysia

B3-0004 A national survey on availability, price and affordability of paediatric-formulations of carbamazepine in a resource limited countryRamasamy Balasubramaniyam, Sri Lanka

B3-0005 Use of clonazepam and avoidance of sleep deprivation in the treatment of juvenile myoclonic epilepsyMohammad Rafiei, Iran

B3-0006 A pilot study of localization of the primary sensory and motor cortex by intra-operative somatosensory evoked potentials in epilepsy surgerySamantha Soe, Australia

B3-0007 seizure alarm dogs for children with nocturnal seizures: preliminary consumer involvement and feasibility studyManish Prasad, UK

B3-0008 neonatal seizure characteristics and outcomes: a study from a tertiary care paediatric centre in IndiaLokesh Lingappa, India

B3-0009 Prognostic overview of catastrophic epilepsies starting in the infantile periodMiho Fukuda, Japan

B3-0010 A clinical study of five infants who presented with irregular and abnormal ocular movementsMuneaki Mtatsuo, Japan

B3-0011 Incidence of kidney stones in children taking topiramate in Hong KongKwan-ming Yam, Hong Kong

B3-0012 sympathetic withdrawal in syncopes: lessons from paroxysmal extreme pain disorderJohn Stephenson, UK

B3-0013 Assessing the conceptual content in health status and quality of life instruments in paediatric epilepsy using World Health organization definitionsGabriel Ronen, Canada

B3-0014 Dravet syndrome - genetic analysis of sCn1A and PCDH19 mutations for 17 Chinese childrenCheuk-Wing Fung, Hong Kong

B3-0015 Change in cognitive functioning after paediatric temporal lobectomyAlexandra Johnson, Australia

88 www.icnc2012.com


eDn

esD

AY30

tH M

AYPo

steR

ses

sIo

ns

B3-0016 effects of KCnQ channel openers on pentylenetetrazole-induced seizures in knock-in mice harboring KCnQ2 mutationsYuko Tomonoh, Japan

B3-0017 Cost savings of the ketogenic dietSophie Calvert, Australia

B3-0018 the characteristics of partial seizures in patients with periventricular leukomalaciaMotomasa Suzuki, Japan

B3-0019 early onset and focal spike discharges as indicators of poor prognosis for myoclonic-astatic epilepsyTakahito Inoue, Japan

B3-0020 Chromosome 5q14.3 deletion syndrome: distinctive electroclinical pattern of two casesChoong Yi Fong, Australia

B3-0021 the prevalence of psychosocial impairment in children with epilepsy seen at a university hospital in the PhilippinesJanet Adajar, Philippines

B3-0022 An international collaboration to undertake clinical research in epilepsy: the epinet projectPeter Bergin, New Zealand

B3-0023 In vitro predictors of severe hypersensitivity reactions to antiepileptic drugsPaul Hwang, Canada

B3-0023a Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugsPaul Hwang, Canada

B3-0024 Prevalence of HLA-B alleles in paediatric patients with adverse drug reactions due to carbamazepineKok Wee Chong, Singapore

B3-0025 Ketogenic diet: is there a relation between neurophysiologic findings and clinical response?Guillermo Agosta, Brasil

12:30-13:30 Poster session: neuroimmunology exhibition Hall

C3-0001 efficacy and safety of interferon beta treatment in Polish children with multiple sclerosisSergiusz Jozwiak, Poland

C3-0002 treatment with intensive intravenous immunoglobulin in recurrent and multiphasic forms of acute disseminated encephalomyelitisMaria Davila, Puerto Rico

C3-0003 First acquired demyelinating syndrome and risk of multiple sclerosis amongst singapore childrenTerrence Thomas, Singapore

C3-0004 A retrospective study of the incidence of paediatric multiple sclerosis in Western Australia over the last 30 yearsSnehal Shah, Australia

C3-0005 WItHDRAWnKıvılcım Gücüyener, Turkey

C3-0006 Risk of multiple sclerosis after a first episode of central nervous system inflammatory demyelination in children from new south Wales, AustraliaEsther Tantsis, Australia

C3-0007 neuromyelitis optica in childhood: identification, investigation and treatment optionsEsther Tantsis, Australia

89www.icnc2012.com


WeD

nes

DAY

30tH

MAY

Post

eR s

essI

on

s

C3-0008 Acute transverse myelitis as a presenting feature of systemic lupus erythematosus in a childSubramanian Ganesan, UK

C3-0009 Miller Fisher syndrome - atypical presentation without preceding illness in a young childSubramanian Ganesan, UK

C3-0010 Clinical variants of Guillain-Barré syndrome in childrenKuang-Lin Lin, Taiwan

C3-0011 Risk factors for respiratory failure and outcome in children with Guillain-Barré syndromeMei-Hua Hu, Taiwan

C3-0012 electrophysiological profile of childhood Guillain-Barre syndrome in northern India: a cross-sectional studySuvasini Sharma, India

C3-0013 Cognitive function in children with multiple sclerosisBanu Anlar, Turkey

C3-0014 A case of acute hemorrhagic leukoencephalitisMasami Togawa, Japan

C3-0015 Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurologyAdriane Sinclair, Australia

C3-0016 Juvenile myasthenia gravis: a case seriesVinay Puri, USA

C3-0017 Immunological study of a child with D-penicillamine-induced generalized myasthenia gravisTakafumi Nishimura, Japan

C3-0018 Autoimmune myasthenia gravis, immunotherapy and thymectomy in childrenTyson Ware, Australia

C3-0019 the neurologic profile of children with inflammatory bowel diseaseNathanel Zelnik, Israel

C3-0020 Rituximab therapy for a boy with opsoclonus-myoclonus-ataxia syndrome resistant to conventional treatmentsAki Ando, Japan

C3-0021 opsoclonus myoclonus syndrome: a study of five patients with response to different treatment and variable outcomeHarshuti Shah, India

C3-0022 Anti-D1- and anti-D2-receptor antibody titers are elevated in children with sydenham’s choreaJonathan Zuccolo, USA

C3-0023 Human monoclonal autoantibody from sydenham chorea patient targets dopaminergic neurons and induces signaling in dopamine D2-receptorsCarol Cox, USA

C3-0024 Acquired neuromyotonia associated with voltage-gated potassium channel antibodies: a case reportTakako Fujita, Japan

C3-0025 A new monophasic clinico-radiological phenotype of voltage gated potassium channel complex antibodies presenting with seizures and basal ganglia changesYael Hacohen, UK

C3-0026 Clinical spectrum of Anti-nMDAR encephalitis - a review of a Malaysian seriesTajul Tajudin, Malaysia

C3-0027 Paraneoplastic encephalitis associated with benign ovarian tumors in childrenMei-Hsin Hsu, Taiwan

90 www.icnc2012.com


eDn

esD

AY30

tH M

AYPo

steR

ses

sIo

ns

C3-0028 symmetric basal ganglia involvement - contemporary encephalitis lethargicaShekeeb Mohammad, Australia

C3-0029 Antineuronal antibodies in a heterogeneous “PAnDAs” group with tics and obsessive compulsive disorderAmir Zuccolo, USA

C3-0030 C1q deficiency presenting with systemic lupus erythematosis, progressive spasticity, intracranial calcification and moyamoyaChristopher Troedson, Australia

C3-0031 Clinical presentation and magnetic resonance imaging patterns in children with central nervous system vasculitisJocelyn Lim, Singapore

C3-0032 Can susac syndrome be diagnosed clinically?Venkateswaran Ramesh, UK

C3-0033 Distinct phenotypical clusters in childhood inflammatory brain diseases: implications for diagnostic evaluationSusanne Benseler, Canada

C3-0034 Klein Levin syndrome is a steroid-responsive, non-n-methyl-D-aspartate receptor-mediated encephalitisVirginia Wong, Hong Kong

C3-0035 A pre-pubertal girl with Kleine-Levin syndromeMohammed Jan, Saudia Arabia

C3-0036 Abnormal findings of tc-99m brain single photon emission computed tomography in childhood Kleine-Levin syndromeFang-Hsuan Tu, Taiwan

C3-0036a Clinical and HLA typing analysis in patients with Kleine-Levin syndromeChaw-Liang Chang, Taiwan

C3-0037 Rapid onset obesity and the idiopathic hypothalamic syndrome in childrenPeng Chuan Khoo, Malaysia

C3-0038 neuropsychiatric manifestations in paediatric patients with systemic lupus erythematosusJeong-Ho Lee, Korea

12:30-13:30 Poster session: Development, Cognition and Psychiatry 2 exhibition Hall

D3-0001 WItHDRAWnNeziha Gouider-Khouja, Tunisia

D3-0002 early detection of dyslexia using the response to intervention model and remedial intervention for dyslexia: the tottori University modelTatsuya Koeda, Japan

D3-0003 Voice-specific eeG responses in children with and without pervasive developmental disordersMasumi Inagaki, Japan

D3-0004 Perceptions in mothers of children with pervasive developmental disorders after modified parent trainingHiroko Okuno, Japan

D3-0005 Long-term neurocognitive outcome and auditory event-related potentials after complex febrile seizures in childrenMin-Lan Tsai, Taiwan

D3-0006 special needs unlimited group (snUG): retreats for families with neurologically disabled children in new south WalesRob Smith, Australia

91www.icnc2012.com


WeD

nes

DAY

30tH

MAY

Post

eR s

essI

on

s

D3-0007 effectiveness of low dose of L-dopamine in children with autism and attention-deficit hyperactivity disorderKyoko Hoshino, Japan

D3-0008 Investigating hospital morbidity in individuals with intellectual disability and/or autism spectrum disorders using the Western Australian Data Linkage systemHelen Leonard, Australia

D3-0009 the use of harmonised, population representative multinational data to assess the relationship between seasonality, month of birth, and autism: results from the iCARe studyHelen Leonard, Australia

D3-0010 An Italian prospective study of children with autism spectrum disorders: can early treatment change the outcome?Paolo Curatolo, Italy

D3-0011 Characteristics of children displaying autistic behavior attending a developmental clinic in the Western Cape Province, south AfricaPriscilla Springer, South Africa

D3-0012 Pervasive developmental disorders: clinical characters and outcome in African childrenLawrence Mubaiwa, South Africa

D3-0013 Qualitative fidgety movements and Gesell developmental schedules in early infantsMing Li, China

D3-0014 Perception of motion, time and number in preterm infantsGiovanni Cioni, Italy

D3-0015 WItHDRAWnYulia Molova, Russia

D3-0016 WItHDRAWnMahmoud Mohammadi, Iran

D3-0017 Analysis of sulphoconjugation in children with autism and learning difficultiesNimanthi Ekanayake, Sri Lanka

D3-0018 the significance of logopaedic therapy in the pre-speech phase in premature babies suffering from unilateral or bilateral brain lesionVida Gec, Slovenia

92 www.icnc2012.com


URs

DAY

31st

MAY

Post

eR s

essI

on

s tHURsDAY 31st MAY12:30-13:30 Poster session: epilepsy exhibition Hall

A4-0001 Figure of 8 head stereotypy in stxBP1 encephalopathyYoung Ok Kim, Australia

A4-0002 Progressive myoclonic epilepsy with Gaucher type 3a: a challenging diagnosisTajul Tajudin, Malaysia

A4-0003 effectiveness of topiramate and levetiracetam in infantile spasms non-responsive to steroidsAdel Mahmoud, Saudia Arabia

A4-0004 Genetic analysis in the Japanese epileptic patients with mental retardationShinsuke Maruyama, Japan

A4-0005 Frontal lobe epilepsy in childrenHsiu-Fen Lee, Taiwan

A4-0006 Age at first seizure is an important prognostic factor for outcome in paediatric cryptogenic frontal lobe epilepsyInn-Chi Lee, Taiwan

A4-0007 epidemiology and seizure outcomes of children with infantile spasms at a tertiary referral centre in south AfricaSally Ackermann, South Africa

A4-0008 epileptic spasms: experience with a high dose oral corticosteroid protocolTyson Ware, Australia

A4-0009 Verbal sound discrimination in Landau-Kleffner syndrome: a neurophysiological studyMakiko Kaga, Japan

A4-0010 Paediatric neurology via telehealth - cost savingsSharon Gilchrist, Australia

A4-0011 Rhythmic midtemporal theta bursts of drowsiness: two paediatric cases with atypical featuresShekeeb Mohammad, Australia

A4-0012 spectrum of refractory childhood epilepsy from a tertiary care centerMaya Thomas, India

A4-0013 Hypermetabolic FDG-Pet and subclinical eeG fast activity localizing to the ictal onset zone in non-lesional frontal lobe epilepsyDerrick Chan, Singapore

A4-0014 the role of oxidative stress in febrile seizuresMei-Hua Hu, Taiwan

A4-0015 Vitamin D status in children with epilepsy who are taking anticonvulsantsJeesuk Yu, Korea

A4-0016 sibling response to initial anti-seizure medication predicts treatment successSharief Taraman, USA

A4-0017 Cerebellar hamartoma presenting with refractory hemifacial spasms in infancyYoung Se Kwon, Korea

A4-0018 overnight pulse oximetry and iron status in children with epilepsyVeline L’Esperance, UK

A4-0019 Water immersion epilepsy – a rare form of reflex epilepsy in childrenSubramanian Ganesan, UK

A4-0020 Comorbidity of Rasmussen encephalitis and other autoimmune disorders: more than by chance?Dina Amrom, Canada

93www.icnc2012.com


tHU

RsD

AY31

st M

AYPo

steR

ses

sIo

ns

A4-0021 efficacy of rufinamide in two children affected by refractory seizures due to focal cortical dysplasiaRomina Moavero, Italy

A4-0022 Risk factors and predictors in development of epilepsy and current quality of life: a retrospective cohort studyMelody Long, Singapore

A4-0023 Mismatch negativity in children with temporal lobe epilepsyPL Cheong, Taiwan

12:30-13:30 Poster session: neurocritical Care and stroke exhibition Hall

B4-0001 Paroxysmal seizures caused by unrecognized acute myocarditis masquerading as febrile convulsions in childrenYun-Jin Lee, Korea

B4-0002 Apoptosis and expression of nitric oxide synthase in hypoxic ischemic cerebral injury of ratsKeonsu Lee, Korea

B4-0003 Prolonged elevation of serum neuron-specific enolase in children after clinical diagnosis of brain deathYasuhiro Suzuki, Japan

B4-0004 Relationship between sleep status of preterm infants and mother’s parenting stress at nightYoko Asaka, Japan

B4-0005 Genetic, physiological, and other determinants of post-traumatic recovery of consciousness and global outcomeTsz-Yan Milly Lo, UK

B4-0006 Acute serum biomarker levels and brain trauma outcome: early measurement provides superior outcome predictionTsz-Yan Milly Lo, UK

B4-0007 A case of acute myopathy due to a suspected taiwan banded krait bitePing Yi Huang, Taiwan

B4-0008 Clinical predictors of outcome following paediatric cardiac arrestRuksha Bhadresha, UK

B4-0009 Hypocapnia and electroencephalographic seizures in comatose childrenSamson Gwer, Kenya

B4-0010 exploring the “good old days” bias in paediatric mild traumatic brain injuryKaren Barlow, Canada

B4-0011 Primary human herpesvirus-6 infections induce anticardiolipin antibodiesMitsuo Toyoshima, Japan

B4-0012 Hemorrhagic stroke: medical and social problems in childrenKonstantin Pushkarev, Kazakhstan

B4-0013 Moderate dietary restriction reduces p53-mediated neurovascular damage and microglia activation after hypoxic ischemia in neonatesYi-Fang Tu, Taiwan

B4-0014 Call Fleming syndrome preceded by aseptic meningitisVinay Puri, USA

B4-0015 Parent and child concerns over the twelve months following arterial ischemic strokeAnne Gordon, Australia & UK

94 www.icnc2012.com


URs

DAY

31st

MAY

Post

eR s

essI

on

s

B4-0016 Lenticulostriate artery calcification (mineralizing microangiopathy) with subcortical stroke in children: a case series from IndiaLokesh Lingappa, India

B4-0017 Pallor, petechiae and ‘puff of smoke’ in a toddlerPuneet Jain, India

B4-0018 Cerebral vasculopathy: a prominent risk factor for childhood arterial ischaemic stroke in a south African tertiary institutionAlvin Ndondo, South Africa

B4-0019 Acute paediatric ischaemic stroke: a 14-year single centre experienceChristina Miteff, Australia

B4-0020 systemic injection of CD34+ enriched human cord blood cells modulates post-stroke neural and glial progenitor response in a sex-dependent manner in CD1 miceAnne Comi, USA

B4-0021 neonatal cerebral sinus venous thrombosis associated with acquired protein lossMahendranath Moharir, Canada

B4-0022 Childhood basal ganglia stroke following trivial head traumaPrashant Jauhari, India

B4-0023 Acute somatoform unilateral weakness and sensory impairment mimicking vascular stroke: value of Hoover sign and motor evoked potentialsNathaniel Zelnik, Israel

B4-0024 Azathioprine and aspirin in childhood primary arterial stroke: a simple and effective treatment regimenMuhammad Malik, Pakistan

B4-0025 A successful treatment of arterial ischemic stroke with stent insertion in a paediatric patient with congenital heart diseaseHee-Joon Yu, Korea

B4-0026 stroke recurrence in children with congenital heart diseaseGabrielle de Veber, Canada

12:30-13:30 Poster session: Muscle and nerve exhibition Hall

C4-0001 Reliability and validity of outcome measures of at-home visits in a randomized, double-blind, placebo-controlled trial for spinal muscular atrophyTai-Heng Chen, Taiwan

C4-0002 Combined mechanical in-exsufflator and noninvasive ventilation in the treatment of paediatric acute neuromuscular respiratory failureTai-Heng Chen, Taiwan

C4-0003 Combined near-infrared spectroscopy and surface electromyography in Duchenne muscular dystrophy: contraction-induced changes in muscle oxygenationGunnar Buyse, Belgium

C4-0004 Collagen VI: a spectrum of diseaseJohn Bodensteiner, USA

C4-0005 Pathogenesis of sIL1 mutations in Marinesco-sjögren syndromeMari Okada, Japan

C4-0006 Flow cytometric diagnosis of Danon disease (LAMP2 deficiency)Tomonari Awaya, Japan

95www.icnc2012.com


tHU

RsD

AY31

st M

AYPo

steR

ses

sIo

ns

C4-0007 Duchenne and Becker muscular dystrophy - impact on quality of life in first-degree females: a first pilot study in BulgariaStefan Gagaouzov, The Netherlands

C4-0008 skeletal muscle Ct images in a family with hypokalemic periodic paralysis showing variable muscle involvementKeiko Ishigaki, Japan

C4-0009 An open label clinical pilot study of resveratrol as a treatment for Friedreich ataxiaEppie Yiu, Australia

C4-0010 Limb girdle muscular dystrophies in children: a clinicopathological study of 49 casesSheffali Gulati, India

C4-0011 efficacy of alternate day prednisolone in Duchenne muscular dystrophyGholamreza Zamani, Iran

C4-0012 the outcome for inpatients with Duchenne muscular dystrophy in JapanToshio Saito, Japan

C4-0013 Alpha-synuclein is decreased in spinal muscular atrophyGyula Acsadi, USA

C4-0014 Chronic regional pain syndrome: correlation between time from onset of symptoms to diagnosis and time from diagnosis to improvementVinay Puri, USA

C4-0015 Fatal hepatic hemorrhage from peliosis hepatitis in x-linked myotubular myopathy: a case report and review of the literatureTakahiro Motoki, Japan

C4-0016 Congenital asymmetric calf hypertrophy of neurogenic originBernard Echenne, France

C4-0017 skin biopsy as an alternative to muscle biopsy for the diagnosis of Ullrich congenital muscular dystrophyLakshminarayanan Kannan, India

C4-0018 A novel homozygous HADHB mutation identified in a patient with mitochondrial trifunctional protein deficiency: the first report in taiwanWen-Chen Liang, Taiwan

C4-0019 Post-asthmatic myelitis with focal amyotrophyManjunath Ashtagi, UK

C4-0020 Massive hyperCKaemia in childhood: differential diagnosis and managementSimone Ardern-Holmes, Australia

C4-0021 enhancing paediatric neuromuscular patient care through a new Zealand clinical databaseGina O’Grady, New Zealand

C4-0022 earliest prenatal diagnosis of spinal muscular atrophy type 0 – first reported caseVelayutham Murugan, India

C4-0023 An Indian family with two children with congenital myasthenic syndromeVelayutham Murugan, India

C4-0024 Botulism in the infant: neonatal onsetGuillermo Agosta, Argentina

C4-0025 WItHDRAWnNeziha Gouider-Khouja, Tunisia

C4-0026 Identification of genetic causes in children with recurrent episodic muscle symptomsJin Lee, Korea

96 www.icnc2012.com


URs

DAY

31st

MAY

Post

eR s

essI

on

s

12:30-13:30 Poster session: Fetal and neonatal neurology exhibition Hall

D4-0001 Brachial plexus palsy in a regional hospital in Hong KongShun Ping Wu, Hong Kong

D4-0002 Development of epilepsy and West syndrome in neonates with hypoxic-ischemic encephalopathyTakeshi Inoue, Japan

D4-0003 simultaneous electroencephalogram and near infrared spectroscopy study on neonatesTakashi Ohya, Japan

D4-0004 Fast activity during electrographic seizures in neonatesLakshmi Nagarajan, Australia

D4-0005 neonatal seizures and prognosisKyoko Hirasawa, Japan

D4-0006 the relationship between early neuroimaging findings and the outcome of neonatal seizureTzu-Chien Hsu, Taiwan

D4-0007 the temporal evolution of electrographic seizure burden in neonatal hypoxic ischemic encephalopathyNiamh Lynch, Ireland

D4-0008 serum s100B protein and short-term outcome of newborn infants with hypoxic-ischemic encephalopathy treated with moderate hypothermiaMing-Chou Chiang, Taiwan

D4-0009 A nationwide survey on therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy in JapanToshiki Takenouchi, Japan

D4-0010 evaluation of the therapeutic benefit of erythropoietin and caffeine following hypoxic-ischemic injury in a neonatal rodent modelMichelle Alexander, USA

D4-0011 Fetal origin of brain damage in two infants with a CoL4A1 mutation: fetal and neonatal neuroimagingR Jeroen Vermeulen, The Netherlands

D4-0012 Management of severe breath holding spells in a set of twins after onset on first day of lifeRon Loh, UK

D4-0013 towards enhanced early prognoses for preterm-born infants: integrating neurophysiological, neuroimaging and functional assessments at term equivalent ageSimon Finnigan, Australia

D4-0014 Predominant oligodendroglial damage in rat model of periventricular leukomalacia due to neonatal sepsisMakiko Shimazaki, Japan

D4-0015 Differential expression of toll-like receptors in the developing brainRand Askalan, Canada

D4-0016 GABAA receptor alpha subunit protein expression after hypoxia in the neonatal pigletTracey Bjorkman, Australia

D4-0017 Predicting outcomes of term neonates with profound asphyxiaAkiko Takeshita, Japan

D4-0018 Amplitude-integrated electroencephalography in neonatesWon Seop Kim, Korea

D4-0019 Hypoxic-ischemic retinal injury involves neuroinflammation, blood-retinal barrier damage and apoptosis in rat pupsYing-Chao Chang, Taiwan

97www.icnc2012.com


exH

IBIt

oRs

exHIBItoRs LIst

Exhibitor

Allergan

Aurora BioScience Pty Ltd

Batten Disease Support and Research Association

Brisbane Marketing Visitor Information Centre

British Paediatric Neurology Association

CareFusion

Cerebral Palsy League

Compumedics

Durable Medical Equipment

Epilepsy Action Australia

Genzyme, A Sanofi Company

ICNA/AOCNA/ANZCNS

Ipsen Pty Ltd

Korthotics Pty Ltd

Medix 21 Australia

Medtronic Australasia Pty Ltd

Mylestones Mobility

Novartis Pharmaceuticals Australia Pty Ltd

Orthopaedic Appliances Pty Ltd

Orthotic Solutions QLD

Otto Bock Australia

Special Needs Solutions

UCB Australia Pty Ltd

Woodslane Pty Ltd

PBS Information: Tablets: Authority Required. Refer to PBS schedule for full authority information.

Injection: This product is not listed on the PBS.

Please review Product Information before prescribing Vimpat®. The full Product Information is available from UCB Australia Pty Ltd.

VIMPAT® is indicated as add-on therapy in the treatment of partial seizures with or without secondary generalisation in patients with epilepsy ≥ 16 years.1

Reference: 1. Vimpat Approved Product Information. UCB Australia Pty Ltd (ABN 48 005 799 208). Telephone: +61 (3) 9828 1800. Facsimile: +61 (3) 9828 1860. Level 1, 1155 Malvern Rd. Malvern VIC 3144, Australia. Vimpat® is a registered trademark used by UCB Pharma GmbH under license. PC1205_VIM_02

11577_1205_VIM_02_V2.1.indd 1 4/05/12 2:55 PM

99www.icnc2012.com


AU

tHo

R In

Dex

AUtHoR InDexAAbdelmoula, Nouha Bouayed 83Ackermann, Sally 92Acsadi, Gyula 63, 82, 95Adajar, Janet 88Agosta, Guillermo 88, 95Aizaki, Koichi 75Alexander, Michelle 96Amrom, Dina 60, 92Andermann, Eva 41Anderson, Alison 52Anderson, Vicki 39Ando, Aki 89Anlar, Banu 48, 80, 89Arai, Hiroshi 86Ardern-Holmes, Simone 82, 95Arroyo, Hugo 68Asaka, Yoko 81, 93Ashrafi, Mahmoud Reza 42Ashtagi, Manjunath 95Ashwal, Stephen 49Askalan, Rand 96Awaya, Tomonari 94

BBadawi, Nadia 49Balasubramaniyam, Ramasamy 87Balk, Marja 42Balslev, Thomas 78Bao, Xinhua 83Barkovich, James 27, 47, 50Barlow, Karen 60, 93Baxter, Peter 40Beca, John 38, 44Bellgrove, Mark 70Benseler, Susanne 50, 60, 85, 90Ben-Zeev, Bruria 41Bergin, Peter 39, 88Berkovic, Sam 29, 34, 39Bhadresha, Ruksha 93Bindu, Parayil 77, 84Birtles, Deirdre 52Bjorkman, Tracey 96Blair, Eve 50Bodensteiner, John 63, 94Bodimeade, Harriet 41

Booy, Robert 31Boustany, Rosemary 44Boyd, Jennifer 69Boyd, Roslyn 33, 51Boylan, Geraldine 63, 68Braun, Kees 29, 58, 63Brilot, Fabienne 62Brink, Philip 86Burns, Joshua 60Buyse, Gunnar 61, 94Bye, Annie 53, 68

CCalotes-Castillo, Loudella 76Calvert, Sophie 43, 88Caraballo, Roberto 43Cardamone, Michael 41Ceulemans, Berten 51Chae, Jong Hee 48Chae, Soo Ahn 76Chan, Derrick 51, 92Chang, Chaw-Liang 85, 90Chang, Ming-Yu 78Chang, Tung-Ming 76Chang, Ying-Chao 96Chang, Yu-Ching 76Chaou, Wun-Tsong 48Chen, Tai-Heng 94Cheong, PL 93Cheong, Pou-Leng 80Cherk, Sharon 78Chiang, Ming-Chou 96Chi, Ching-Shiang 30Chien, Yin-Hsiu 31Chin, Zheng-Nan 79Chong, Kok Wee 88Cho, Sung-Min 75Chou, I-Ching 87Christodoulou, John 26, 27, 30Chugani, Diane 50, 67Chugani, Harry 29, 40, 47, 50, 71Cioni, Giovanni 78, 91Clark, Damian 59Clarke, Nigel 70Claudianos, Charles 26Colditz, Paul 63Collins, John 63Collinson, Joseph 60

Comi, Anne 51, 94Connolly, Mary 31Cooper, Matthew 32Cox, Carol 89Cox, Catherine 76Cross, Helen 27, 29, 43Curatolo, Paolo 67, 82, 91Cvitanovic-Sojat, Ljerka 75

DDale, Russell 25, 29, 43, 62Dalmau, Josep 37Dan, Bernard 29, 39Dasouki, Majed 41, 82Davila, Maria 88De Meirleir, Linda 26de Veber, Gabrielle 57, 59, 62, 69, 94de Vries, Linda 67DiMario, Francis 42Donald, Kirsty 32Dossetor, David 26Downs, Jenny 33, 39, 52Duarte, Sofia 60Dunin-Wasowicz, Dorota 40

eEchenne, Bernard 51, 78, 95Eeg-Olofsson, Orvar 75Efron, Daryl 70Ekanayake, Nimanthi 91Ellaway, Carolyn 41El Shakankiry, Hanan 85

FFan, Hueng-Chuen 84Fan, Pi-Chuan 83Farrar, Michelle 53Fayyazi, Afshin 74Fehr, Stephanie 41Ferguson-Pell, Martin 53Fernandez-Alvarez, Emilio 34Fernando, Sanjaya 86Ferrie, Colin 38, 43Ferriero, Donna 47, 58, 63Finnigan, Simon 96Fong, Choong Yi 60, 74, 88Francis, MV 49, 84Frank-Briggs, Angela 76, 86

100 www.icnc2012.com


UtH

oR

InD

ex

Franz, David 34Fujita, Takako 89Fujiwara, Dirce 83Fukuda, Miho 87Fukuda, Mitsumasa 87Fung, Cheuk-Wing 77, 87Fung, Eva 79Fushiki, Shinji 48Futaisi, Amna 77

GGaebla-Spira, Debra 53Gagaouzov, Stefan 95Ganesan, Subramanian 83, 89, 92Ganesan, Vijeya 50, 58Garcia, Marisela 83Gascoigne, Michael 40Gec, Vida 91Gecz, Jozef 34Geller, Thomas 82Ghezzi, Angelo 48Gilchrist, Sharon 32, 92Gordon, Anne 60, 93Goto, Ayako 81Goto, Yuichi 34Gouider-Khouja, Neziha 74, 83, 90, 95Govender, Rajeshree 84Govender, Vasantha 75Graham, Kerr 48Grant, Ellen 58Grattan-Smith, Paddy 26, 34, 37, 40Gregersen, Niels 44Gross-Tsur, Varda 60Guandalini, Michael 84Gücüyener, Kıvılcım 88Guerreiro, Marilisa 58Gulati, Sheffali 61, 79, 95Gunji, Atsuko 26Gunn, Alistair 44Gupta, Rashmi 52Gupta, Sachin 33Guzzetta, Andrea 61Gwer, Samson 32, 37, 93

HHacohen, Yael 52, 89Hara, Munetsugu 81Harvey, Simon 29

Hayashi, Masaharu 52Hayflick, Susan 54Hellstrom-Westas, Lena 63, 68Heron, Sarah 68Heussler, Honey 67Hidaka, Hideyuki 83Higurashi, Norimichi 37Hino, Hitomi 51Hirano, Yoshiko 79Hirasawa, Kyoko 96Hirose, Shinichi 59, 67Hodge, Jacquie 84Hogarth, Penny 54Hoshino, Kyoko 91Howell, Katherine 61Hsu, Mei-Hsin 89Hsu, Tzu-Chien 96Huang, Chao-Ching 70Huang, Ping Yi 93Huang, Wei-yuan 84Hu, Chih-fen 75Hu, Mei-Hua 89, 92Hung, Pi-Lien 61Hwang, Paul 88Hwang, Su-Kyeong 40

IIdro, Richard 49Iinuma, Kazuie 48Inaba, Yuji 81Inagaki, Masumi 90Inoue, Takahito 88Inoue, Takeshi 96Iscan, Akin 76Ishigaki, Keiko 95Iwasaki, Hiroyuki 76Iwasaki, Nobuaki 33

JJackson, Graeme 27Jain, Puneet 77, 79, 94Jan, Mohammed 39, 40, 83, 90Jansen, Anna 41Jardine, David 43Jauhari, Prashant 94Jiang, Li 76Jiang, Yuwu 32, 34Johnson, Alexandra 84, 87Johnston, Michael 44Jong, Yah-Jyh 63Jozwiak, Sergiusz 42, 74, 88

Jóźwiak, Sergiusz 35

KKaga, Makiko 92Kamate, Mahesh 84Kanemura, Hideaki 74Kang, Hoon-Chul 43Kang, Joonwon 79Kanna, Lakshminarayanan 95Karimzadeh, Parvaneh 74Kashii, Hirofumi 86Kato, Mitsuhiro 27, 59Kato, Noriko 81Kaufmann, Walter 34, 67Kava, Maina 77, 83Khan, Naila 48, 58Khoo, Peng Chuan 90Khoo, Teik Beng 87Kieffer, Valentina 81Kihara, Mike 58Kim, Dong Wook 79Kim, Eunyoung 76Kim, Heung Dong 29, 74Kim, Jon Soo 82Kim, Seung-Ki 69Kim, Sung Koo 77Kimura, Kazue 33Kim, Won Seop 85, 96Kim, Young Chang 83Kim, Young Ok 32, 92Kirkham, Fenella 49, 62, 69Kirton, Adam 51Kitai, Yukihiro 86Kitamura, Yuri 77Koeda, Tatsuya 90Koga, Yasu 30Kokooza, Angelina 47Komárek, Vladimír 76, 84Korff, Christian 31Koskinen, Suvi 84Ko, Tae-Sung 74Kotagal, Suresh 59Kotulska, Katarzyna 77, 81Koyama, Akiko 82Kraus de Camargo, Olaf 39Krueger, Darcy 42Kubota, Masaya 78Kubota, Tetsuo 63Kumada, Tomohiro 74Kuntz, Nancy 53, 68

101www.icnc2012.com


AU

tHo

R In

Dex

Kwong, Karen 74Kwon, Young Se 74, 92

LLagae, Lieven 70Lahat, Eli 70Lah, Suncica 40Laing, Nigel 69Lawson, John 35, 47, 81, 82Lee, Eun Hye 79Lee, Hsiu-Fen 92Lee, In Goo 80Lee, Inn-Chi 92Lee, Jeong-Ho 90Lee, Jin 95Lee, Keonsu 81, 93Lee, Kyung Yeon 76Lee, Wang-Tso 30, 82Lee, Yun-Jin 93Leonard, Helen 27, 39, 81, 91Lerman-Sagie, Tally 27, 58L’Esperance, Veline 92Leventer, Rick 27Liang, Jao-Shwann 79Liang, Wen-Chen 95Li, Ling 76Li, Ming 91Lim, Jocelyn 90Lin, Cindy 53Lingappa, Lokesh 84, 87, 94Lin, Jainn-Jim 32Lin, Jean-Pierre 34, 48Lin, Jeremy 79Lin, Kuang-Lin 89Lin, Lung-Chang 74Linn, Kyaw 48Loh, Ron 76, 96Long, Melody 93Lo, Tsz-Yan Milly 93Lourenco, Charles 33, 76, 77, 82Lo, Warren 68Lukban, Marissa 30Lynch, Niamh 61, 96

MMacefield, Vaughan 43Mackay, Mark 58, 59, 62, 79Mack, Kenneth 59MacLennan, Alastair 49Maezawa, Mariko 80

Mahajnah, Muhammad 77Mahmoud, Adel 74, 92Majnemer, Annette 47Malik, Muhammad 94Mallewa, Mac 38Malone, Steve 47Mandal, Bappaditya 74Mandelstam, Simone 42Marini, Carla 62Martino, Gabriel 83Maruyama, Shinsuke 92Matsubayashi, Tomoko 75Matsufuji, Mayumi 86Matsui, Gakuyo 86Matsushita, Shoko 75Ma, Yinan 78McIntyre, Sarah 50McTague, Amy 32Medina-Crespo, Violeta 77Mefford, Heather 50Meirleir, Linda De 30Miike, Teruhisa 40Mikati, Mohamad 68Mimaki, Masakazu 32Mine, Jun 78Mink, Jonathan 25, 34, 78Miteff, Christina 94Miteff, Ferdi 70Miyata, Rie 32Mizuguchi, Masashi 30Moavera, Romina 74Moavero, Romina 93Mochida, Ganeshwaran 41Mogami, Yukiko 79Mohammadi, Mahmoud 91Mohammad, Shekeeb 76, 90, 92Moharir, Mahendra 67Moharir, Mahendranath 94Molova, Yulia 91Morioka, Shigemi 84Motoki, Takahiro 95Msall, Michael 86Mtatsuo, Muneaki 87Mubaiwa, Lawrence 91Murray, Ian 83Murugan, Velayutham 78, 95

nNagarajan, Lakshmi 68, 96

Nagasawa, Tetsuro 86Naidu, Sakku 59Nakai, Akio 26Nakajima, Keisuke 32Nakamura, Yuki 40Nakayama, Tomohiro 78, 80Nardocci, Nardo 25Narita, Aya 33Natsume, Jun 51Ndondo, Alvin 94Nesterovskiy, Yury 83Newton, Charles 37, 38Ng, Joanne 60Nickels, Katherine 80Niijima, Shinichi 70Nishimura, Takafumi 89Nishino, Ichizo 57Nomura, Yoshiko 25, 27Nonaka, Ikuya 67North, Kathryn 34, 57, 70Novak, Iona 39

oO’Callaghan, Finbar 30, 35, 63, 69O’Grady, Gina 95Ohta, Sayaka 42Ohya, Takashi 96Okada, Mari 94Okano, Hideyuki 57Okumura, Akihisa 63, 70Okuno, Hiroko 90Ouvrier, Robert 26, 67, 70

PPetrou, Steve 62Phitsanuwong, Chalongchai 82Pillai, Sekhar 52Plecko, Barbara 38Pohl, Daniela 52Poll-The, Bwee-Tien 25, 34Poretti, Andrea 57, 62Prasad, Asuri 30Prasad, Chitra 26Prasad, Manish 80, 87Prasad, Narayan 26Puri, Vinay 82, 89, 93, 95Pushkarev, Konstantin 93



UtH

oR

InD

ex

RRafiei, Mohammad 87Raj, Satish 43Ramesh, Venkateswaran 80, 90Randall, Melinda 51Rees, Mark 69Rho, Young-Il 83Richards, Linda 27Riikonen, Raili 33, 59Riney, Kate 29, 52, 57Riordan, Gillian 79Robertson, David 42, 43Rodda, Jill 51, 74Ronen, Gabriel 39, 87Rosemberg, Sergio 69, 71Rust, Rob 62Rust, Robert 85Ryan, Monique 68, 69

sSadleir, Lynette 53Saha, Narayan Chandra 83Saini, Arushi 86Saito, Toshio 95Sakakihara, Yoichi 29, 57, 80Sakaue, Yuko 79Sakuma, Hiroshi 43Salman, Michael 41, 57, 62, 69, 82Samia, Pauline 81Sanger, Terence 37, 48Sarajuuri, Anne 84Sarnat, Harvey 61Sasaki, Masayuki 26Scheffer, Ingrid 37, 62Schoeman, Johannes 38, 75Scott, Rod 38Sebire, Guillaume 58, 63Segawa, Masaya 25, 30, 53Seppi, Inês 86Shaanvar, Shamansurov 85Shah, Harshuti 89Shah, Snehal 80, 88Sharma, Suvasini 40, 89Shevell, Michael 33, 47, 51, 78, 80, 86Shibuya, Ikuhiko 81Shiihara, Takashi 75Shimazaki, Makiko 96Shimoda, Konomi 77

Shimomura, Hideki 75Shintaku, Haruo 38Shioda, Mustuki 74Sinclair, Adriane 89Singer, Harvey 25, 31Singhi, Pratibha 30, 31, 38, 47, 63Singhi, Sunit 38Smith, Rob 90Soe, Samantha 87Soga, Nami 79Solomons, Regan 75Springer, Priscilla 91Stanley, Thorsten 76Stephenson, John 42, 43, 87Stevenson, Nathan 61Stockler, Sylvia 38, 59Stowe, Robert 78Sue, Carolyn 25Sugai, Kenji 79Suzuki, Motomasa 88Suzuki, Yasuhiro 93Suzuki, Yoshiuki 38, 44

tTachibana, Masaya 80Tajudin, Tajul 89, 92Takada, Satoshi 48Takahashi, Yukitoshi 62Takanashi, Jun-ichi 40, 43Takano, Tomoyuki 80Takeda, Taisuke 42Takenouchi, Toshiki 96Takeshita, Akiko 96Tando, Tomoko 80Tan, Seong Seng 27Tantsis, Esther 88Tanuma, Naoyuki 32Taraman, Sharief 92Tardieu, Marc 44, 49, 68Tay, Stacey 77Teh, Chee-Ming 31Tehrani, Fereshteh Saeed 77Tein, Ingrid 26, 30, 37, 44Temudo, Teresa 31Terashima, Hiroshi 84Thomas, Maya 92Thomas, Terrence 82, 88Thorburn, David 25, 34Togawa, Masami 89

Tohyama, Jun 74Tomoda, Akemi 84Tomonoh, Yuko 88Toorn, Ronald Van 75Topaloglou, Haluk 57Topcu, Meral 39Toyoshima, Mitsuo 93Troedson, Christopher 90Tsai, Jeng-Dau 81Tsai, Min-Lan 90Tu, Fang-hsuan 90Tu, Yi-Fang 93

UUchida, Taku 81Urbanowicz, Anna 52Urion, David 86

VVaddadi, Gautam 43Vajsar, Jiri 54Vanhatalo, Sampsa 58van Karnebeek, Clara 59Varadkar, Sophia 57Vargha-Khadem, Faraneh 58Venter, Andre 70Vermeulen, R Jeroen 86, 96Vincent, Angela 53, 57, 62Vles, Johan 75, 86Vries, Linda de 63Vucic, Steve 53

WWahab, Abdul 79Walker, Karen 52Wallace, Geoff 29Waller, Susan 47Wang, Furene 76Wang, Huei-Shyong 78Wang, Jing-min 83Wang, Jingmin 42Wang, Jing-Min 41Ware, Tyson 77, 89, 92Webster, Richard 71Weckhuysen, Sarah 37Weiss, Shelly 67Whiting, Sharon 37Wilcken, Bridget 26, 31Willemsen, Michèl 30, 33, 77, 82Willerslev-Olsen, Maria 87

103www.icnc2012.com


AU

tHo

R In

Dex

Wilmshurst, Jo 38, 67, 68, 70Wise, Grahame 77Wong, Virgina 27Wong, Virginia 54, 67, 80, 90Woo, Young-Jong 75, 80Wu, Shun Ping 96Wu, Ye 54, 82

xXiong, Hui 54, 61

YYamada, Keitaro 77Yamamoto, Hiroyuki 79Yamamoto, Hitoshi 68, 71Yamani, Suad Al 60, 71Yamashita, Yushiro 81Yam, Kwan-ming 87Yang, Ming-Tao 80Yapici, Zuhal 75Yatsuga, Shuichi 77Yau, Eric 77, 80Yeh, Geng-Chang 81Yiu, Eppie 53, 61, 95Yonee, Chihiro 75Yoon, Grace 57, 62Yoshioka, Seiichiro 82Yu, Hee-Joon 94Yu, Jeesuk 92

ZZamani, Gholamreza 95Zelnik, Nathanel 89Zelnik, Nathaniel 94Zhang, Feng 50Zhang, Yue-Hua 31Zheng, XiangRong 86Zubcevic, Smail 84Zuberi, Sameer 37, 53Zuccolo, Amir 90Zuccolo, Jonathan 33, 89

© T

race

y Ta

ylor

| Dre

amst

ime.

com

105www.icnc2012.com


no

tes


Joint 12th ICNC and 11th AOCCNn

ote

s

107www.icnc2012.com


no

tes


Joint 12th ICNC and 11th AOCCNn

ote

s

ICNCAOCCN

2012BRISBANEAUSTRALIA

www.icnc2012.com

© Pniesen | Dreamstime.com

Documents

FULL PROGRAMME - Event Campaign